Health Horizons
Bringing clarity to the biggest topics in workplace health
Health Horizons explores the key health and wellbeing issues shaping how we work and live. We explore trends, share evidence-led insight, and offer practical tips you can use to support your people with confidence.
Latest event:
Cancer care reimagined: Early detection and personalised support
By 2040, it is expected that someone will be diagnosed with cancer every two minutes, in England.1 As prevalence continues to rise, advances in diagnostics and treatment are transforming how cancer is detected and managed.
We explore the trends reshaping cancer care and what they mean for employers. We share the latest developments in cancer screening and treatment, alongside how Bupa is evolving its cancer proposition through innovative prevention pathways, personalised support and practical strategies that can help organisations improve outcomes.
We also take a closer look at prostate cancer, examining current challenges, opportunities for earlier detection and what employers can do to support their workforce.
Approximately 160,000 people of working age receive a cancer diagnosis every year in the UK.
890,000 people of working age are living with cancer and this is set to increase to 1,150,000 by 2030.
Research shows 96% of organisations do not have a cancer-specific workplace policy.
Good morning, everyone, and welcome back to Health Horizons. It’s great to have you with us. In today's session we're excited to be sharing insights
across both PMI and IPMI propositions, this is part of our commitment to connect and simplify insights across
our complete portfolio of healthcare solutions. So a big welcome to some new guests and intermediaries who
join us from our UK-based Bupa Global partnerships, So, today we’ll be discussing the latest advancements and
trends in cancer prevention, diagnosis and treatment. We’ll also explore what this means for employers, and
how Bupa can help support better outcomes. Let’s start by highlighting why we think this topic
should be a priority for all businesses. 160,000 people of working age receive a cancer
diagnosis every year in the UK. 890,000 working-age people are living with cancer,
which is expected to rise to 1.15 million by 2030. And, recent survey shows 96% of organisations do not
have a cancer-specific workplace policy. These figures make one thing clear: cancer is a
workplace issue, and with more people living and working with cancer, employers and healthcare partners have an increasingly important role to play together in
making sure people feel supported. We believe prevention and more personalised support are key to unlocking better outcomes. Our experts will
explore what this could look like, diving deeper into the innovations and approaches shaping the future of
cancer care. Let’s meet our expert speakers. Today I’m delighted to be joined by: Robin Clark, Medical Director, Bupa
Global and UK Insurance Robin is responsible for providing clinical oversight and support to the
development and delivery of Bupa services, including our cancer pathways. Amy Rylance - Director of Health Services, Equity &
Improvement, Prostate Cancer UKGood orange Amy.
Aim is to raise awareness engame with health and early
diagnose and creation of the charity. Carly Cryer, Partnership and Business Development
Manager, at Bupa Carly works with intermediaries and organisations to bring health and wellbeing solutions
to more people, helping improve health outcomes and workplace wellbeing. Carly has personal experience of cancer and will share
valuable first-hand insights throughout the session. As always please send questions throughout the session and we'll answer as many as we can later on, we know
you love a poll so we have two polls, you will be super excited for that, look out for that later.
We have loss to get there you, firstly, Robin what, is
the biggest trends you see in cancer and diagnosis in UK and internationally.
ROBIN: Let's do scene setting, within the UK we have avenue about 3.5 million people living with cancer,
that's expected to rise, so the expectation is about 5.5 million people will be living with cancer by 2045
in the UK. Now within that number, there's estimated 900,000 working age people and again if you think about the
increases I've just explained that 900,000 is expected to increase 1.15 million by 2030, so that highlights
your intro point about the impact of importance of the topic for businesses.
But I think in terms of positive trends, cancer survivors are higher than ever before.
So, and that's approximately doubled since the '70s, 50 % of people diagnosed with cancer expected to survive
for ten years or more, so good signs in progress there. On a global perspective, again, cancer still one of the
most significant global challenges that we face today. So worldwide we're seeing over 20 million in new
diagnoses each year, a massive burden and that number is expected to substantially increase over coming
decades. But, if you look at what naps terms of variation across the globe with regards to treatment and outcomes, I
think breast cancer a good example, five year breast cancer survival rates are 87% in high income countries,
but compared to many lower income countries that's approximately 42%. So, about half. So there is a quite discrepancy on country by country
basis. What that highlights is the critical role about early diagnosis, getting the right treatment and helping
navigate people through the right care channels. RICHARD: Great progress but leaders need to be thinking
about, in their day to day in a business. Carly, I will come to you, could you start by telling us about
yourself and your cancer journey. CARLY: Obviously I'm Carly Cryer Business Development Manager for Bupa, I'm a mum, and I have two children
although home, I was diagnosed with breast cancer in 2025, so I'm about a year in post diagnosis now I have
a pragmatic view on things, when things happen I take it as a find it with the breast cancer, I was like
what's going to happen and how do we face into it. I was superremember delighted to have private health
insurance, I got quick intervention, and quick surgery and intervention which really helped I think with my
journey to be honest. And I am taking on going medication now, my cancer
journey meant I have to have surgery radiotherapy and on going medication to hopefully keep my cancer away so
that's my journey up to now. RICHARD: Thank you for sharing. Amy, I will come to you next.
Prostate cancer UK you support thousands of people, can you tell us about cancers impact on livelihoods.
AMY: Prostate cancer is the most common cancer in the UK, and it mostly impacts men over the age of 50.
But there are a couple of groups of men for whom the impact is bigger and it starts at a younger age, so for
black men, and men who have a family history of the disease, for them, from their mid-40s, so what that
means in terms of a working age population, we see almost 25,000 men diagnosed each year who are of
working age. And so, clearly, that is going to have a really significant impact on people's ability to work.
And that impact really varies depending on the stage of diagnosis, Robin talked about early diagnosis, what we
know with prostrate cancer the earlier you find it the easier to treat.
If we treat it at early stage it can have minimal impact on people's ability to work, it maybe they need
to go for monitoring appointment every couple of months. If the cancer a more aggressive they're going to need
surgery or radiotherapy and time out for that treatment, and for the recovery afterwards.
If men are diagnosed at the point their cancer is incurable so the point it has spread through their body
the treatments at that point are really intensive so that is going to have a really big impact on people's
ability to work. What we do know though, is those treatments are getting much better.
So, I think, there is sometimes a perception that diagnosis of incurable cancer means the end of your
working life and we're increasingly seeing that is not true and people are able to continue working, and
actually live good lives with incurable cancer. RICHARD: Scary statistics. Very scary statistics.
So, Robin. Around four in ten cancer caseness the UK can be
prevented with historically thought cancer healthcare in terms of finding and treating disease, are we now
entering a period prevention is going going to become a bigger part. ROBIN: That's definitely the direction of travel,
historically, we focused on find and treat be cancer, but now the proportion of cancers can be prevented, and
so, I think the future is very much more likely to be personalised and about understanding the risks of an
individual and helping them to mitigate those risks and make the necessary changes.
So, I think it is going to be very much focused about using risk assessment, understanding family history,
genetics and data sources to identify who is likely to be at risk and then support intervention at the
earliest opportunity. So, I think, yeah, very much using those tools to identify who should we offer screening to, there's new
screening tools down the pipeline as well. So, very much, pulling all that together to really
offer those material impactful things to individuals. So prevention is not only better for the individual's
themselves but actually in terms of the healthcare system it is far better in terms of utilisation of the
available resources too, so overall it is the direction of travel and something we should be heavily investing
in. RICHARD: That's the end of our first session, we clearly made the case for employers to get involved in
prevention and identification up front, it is such a big impact on the workforce. It has been really interesting how cancer diagnosis and
care is impacting on the impact of cancer having on lives, thank you for sharing your story.
And it is clear prevention and early diagnosis has important role to play in ensuring better outcomes.
So, I know this is the moment you've all been waiting for, our first poll, does your organisation provide
support, services for those affected by cancer, yes or no. We'll give you the answers later lone.
The second part of our discussion now, so, for the second part of the day's session, we will look at
innovations shaping the future of cancer care to AI and personalised approaches to treatment. We'll explore,
what theses developments could mean for patients and employers, and what Bupa services are available to
support people through their cancer journey. OK, Amy, to you first.
So, what are the biggest misconceptions around prostate cancer that you would like employers and employees to
better understand. AMY: Yeah. I'm going to go with two, so the first one, is the test
for prostrate cancer, there is a very strong belief that involves a finger up the bum. And what we know,
is that the blood test, PSA blood test is a much better test for prostrate cancer so you don't have to have
intimate examine to test for the prostate cancer, the biggest reason men are wary is because of the taboo
about testing, so, really hammering home the fact that the best test for prostate cancer is a blood test.
I think the second misconception, is the idea that all cancer is the same, all cancer is terrifying, all
cancer is a killer, and within prostate cancer it is a really broad spectrum of disease.
So, some prostate cancer, absolutely it is a killer disease. But, for lots of men, they get diagnosed with a type of
prostate cancer which is so, slow-growing, that actually the treatment causes more harm than the cancer
ever would. And so, I think, one of the big challenges we have in
prostate cancer, is helping people to understand that the treatment that's best for them will vary hugely
depending on the type of cancer that they have. And actually, as a healthcare system whether that's in
the NHS or more broadly, we now really good at understanding which of those slow-growing cancers, and
which of the ones that need aggressive treatment. So, it's having that ability to trust that actually
when we say, let's not treat this cancer, let's monitor, and see what happens, check whether it's
behaving in any unexpected ways, actually that's the better route for some people rather than having the
burden of side effects that comes with treatment. RICHARD: Personalisation is so important rather than
one-size-fits-all and get tested. It is like, it has to be worth it surely.
OK, Robin, can you tell us, how cancer diagnosis and
monitoring is evolving and what that means for patients
and employers. ROBIN: Coming early, less invasive and personalised. And there's a lot more tools we use, increasingly, we
have blood tests, we have more gather no, mammic information we can use advance analytics, that helps us
identify disease at the earliest stage as we've heard is preferrable for everyone. If we can do that.
It also allows us with the new tools and techniques to monitor the disease and the progress and how well
treatment is working as well. So, that allows us to identify how successful the treatment is being, but also, whether there's any signs
of recurrence and we can pick that up, sooner than ever before. So, there's tests such as liquid biopsies via blood
tests that identifies fragments of the cancer DNA circulating in the system, using these tests rather
than biopsy of the tissue, it is easier to do the testing and years for someone going through the journey
because they don't need to spend so much time spending time in hospital and going to hospital so it is more
convenient way of practising medicine and more effective overall. Overall yes, it is at least the faster diagnosis and
better outcomes. So, obvious benefits there for patients in terms of their experience and business perspective that also
really helps for their employee base, and helps that they can stay productive and in the workplace and need
less time off so it is a win/win on both fronts. RICHARD: More motivation point now or becoming more
motivation to get tested rather than the barrier being the healthcare. Employers have a big role to play.
Amy, so where is AI already beginning to change prostate cancer detection or care, and where do you see
its greatest future potential. AMY: I think, there's sort of three categories, there's
where it is already being used, where it is being used in a sort of assistant mode but not taking over from
clinical decision-making. And where we see its use in the future where it will become exciting.
So in terms of use already, on the NHS, radiation planning, so, this used to be an incredibly laborious
task a radio therapist would draw on the radiation field on people's scanses, AI routinely does this, and
checked by the clinician rather than the clinician spending hours doing it up front.
In that space of imaging that's where we see AI make really big, fast progress, so, for prostate cancer we
give men MRI scanning we're increasingly seeing AI used as an assistant effectively in reading those MRI scans,
so, flagging the scans that are really you are Gwent, making sure you put them to the top of the pile those
one sincere a big red flag and almost certainly cancer there. Where I think we'll get to in the near future is AI
calling the obvious yes and no and we're using clinicians for the borderline cases.
I think similarly for pathology, so when we're looking at cancer cells or cells under the microscope and
deciding whether they're cancer and if they are how aggressive is that cancer, again, that is very open to
AI, and we're seeing some really exciting work happening in that space. So, that we can use AI to read either a alongside
pathologist or first read for pathologist. The where we're not seeing in clinical practice but we'll get
there relatively soon, actually is the space of personalisation, so picking up on points that Robin's
made, we know that different prostate cancer behave differently, there's a broad spectrum of treatments and
have different side effect profiles. At prostate cancer UK we're looking at a piece how do
we know which men get the most benefit from chemo, it is using AI to look at blood test results, scans and
all sorts of factors and say, well actually we can see this cohort of men, do really well with chemo so the
side effects the burden that chemo puts on people, that's worth it, if you're in this group.
But actually for this group, it doesn't seem to make any difference so why put them through all the side
effect, and if this group know we can say have different treatment, don't have chemo. So AI in terms
of personalisation of treatment choices, is going to be huge. And then the final thing I'd say in that support space,
I think, we're all so used now to having you know, the
ability to, we were talking earlier chat GTB ask questions of AI, and bots, that's the wrong word, that
space where you can have assistant to help you understand and navigate your journey with cancer is
incredibly powerful and we'll see huge progress around that. RICHARD: So personalisation, humanoids in the loop,
horrible phrase but it does what it says on the tin, navigation point, better than Googling, isn't it, as
long as it is settle up right. But, it is all good stuff, cancer treatment is becoming
increasely personalised what does personalised cancer care look in practice and how do we make these
advancements sustainable and affordable. ROBIN: Very much building on the points we just heard. So, those personalised treatments are very much based
around understanding the individual differences that make that person's tumour unique, so, doing the testing
on them to understand what it is that gone wrong within the particular tumour that is potentially treatable.
But also, understanding the difference, that individual unique, so things about their own biology, so, again,
back to the test, genomic tests, different Biomarkers we can test for, liquid biopsies and using the result
of all those to match the therapy to that particular tumour type or subtype.
By doing that, that actually increases the likelihood of that treatment working but also, importantly on the
Flip side it reduces the amount of unnecessary or wasteful treatment that might otherwise occur.
So that's an important thing to call out here. So, we're not suggesting using these tools just for the
sake of using them because they're there, but there's benefit to the individual and benefit to treating
disease and benefit to the healthcare system so it is a good way of helping to manage healthcare costs.
So, actually by, enabling better use of diagnostic, and better use of the monitoring tools, and by ensuring
carers evidence based on treatment and test results and given the right treatment first time it helps, create a
sustainable healthcare system too. So, yeah, lots of benefits in that sort of methodology.
RICHARD: Better outcome as well, if you're using the right medication, Carly, we talked about the personal
size the support and how that is coming into cancer care, you've been open about your experience with
Bupa's Medication Check service, can you talk us through what the process was like and how it helped you
personally. CARLY: I was part of the genomics pilot that Bupa ran, and I'm nosey so wanted to know more about my history
and things like that. This was precancer diagnosis, so at this point I have no family history of cancer, I don't think I'm going to
get cancer, none of us expect to get it. It was a simple saliva test, the report came back and
identifies how I personally metabolize over a hundred common medications I had a quick read and put it in the
drawer, completely forgot with it, when I got my cancer diagnosis and started talking so oncologist and
treatment plans and things like that, hang on a minute, I thought I had to pull out the medication out, one of
the things with cancers, you will need medication for extended period of time and I wanted to see what my
Medication Check said. I showed it to the oncologist who never had seen it before, he was open to see it and asked if they could
have a copy and share it among colleagues, that's how healthcare innovate and keep moving forward.
We had a chat about it, and we the drug that was suggested for me, I was absolutely a poor member tap
lieser and couldn't guarantee that drug could potentially work for me as a treatment. So it gave me, obviously when you're having a cancer
diagnosis for those who have ever been unfortunate to have it, there's a sense of losing control, and not
knowing what is going on, and you are at the hands of this humour and how your journey is going to be, so the
fact it gave me a little bit more Croatia those who know me know I like to be in control, it was great to
chat to oncologist and speak about other options that is available that is more personalised ad will have a
better positive outcome from my journey, from the back of the check, it needed to have additional surgery, I
chose to have my ovaries taken out because I was A positive which means I can't have it in my body and
because I couldn't take the initial medication alternative was to have my ovaries out and try the
other medication, so for me, that was the best outcome from a personalised point of view, but then to touch on
something that Robin said about genomics, I was fortunate in that chatting to the team that were
looking after my care because a lot of them, lots of different people and from employee perspective having
support of employee that understand it was not just one appointment there are several, Bupa was great with
that, I was still going back and forward, you're having the appointments throughout your working time, we sent
my tumour off to America to be checked. So, normally with a cancer diagnosis, I'm pragmatic, I
talked about it, I'm get on with it type of person and I'm strong one in family so I don't need my kids or
husband to be worrying, so I was a big brave front but back of my mind I was afraid of chemo, that's what
everyone thinks will happen and that's what everyone has, but I was of the fortunate that my tumour was sent
to America, they check it against the chemotherapy to Amy's point to see does it respond to chemotherapy,
will I have to have something invasive, expensive to have, and also, would impact me returning to work,
long-term. So, fortunately that came back I wouldn't need to have chemotherapy and best outcome for me is radiotherapy
and parliament of treatment plan, from work's perspective I was back in work much quicker than I
would have been, likely cheaper because I wouldn't have long going chemotherapy but psychological perspective
and personal and family perspective, it meant my journey was so much easier not only for me but children
not to see my hair falling out or bad side effects of chemotherapy, so from my perspective I felt like that
personalisation absolutely made my cancer journey more manageable. RICHARD: Much have been a huge relief.
AMY: Yes. RICHARD: If any employers to win the business case, the
human aspect is fan it's a stack, thank you for sharing. Amy, two months ago promising trial results showed that
personalised cancer vaccine given in combination with a drug helped prevent skin cancer flung some patients.
How close are we seeing a breakthrough similar to this to prostate cancer. AMY: So, the prostate does not have any immune cells
within it. So, the way a vaccine works is it primes your immune
system to fight the disease or the cancer, and so, unfortunately, within the space of prostate cancer,
vaccines aren't an option. , certainly not in the near future, when the prostate
itself doesn't have any cells to be primed, technical term, research colleague was telling me it is immune
cold environment. But that doesn't mean that we're not looking at really exciting break thrust in terms of prostate cancer.
In fact last week, we ran a story that looked at the number of men who were surviving three years post a
diagnosis of incurable cancer. And we've seen that survival rate jump by 25% in just a
couple of years. And that is actually all of the experts agree that is
only going to get better because the data was looking at, ended in 2022, and actually we've had a number of
further treatment break thrust since then. I think what it is doing is opening up whole new
questions for us, and I think, to exemptionfy those questions, there's a gentleman called Kevin who was the
face of our story about the progress we're making and treating prostate cancer, it is a brilliant man, he was
diagnosed with cancer at the age of 48, he was told that his prostate cancer had spread throughout his
body, he had sigmates within his lungs, and he was told he was terminal.
He had just hit three years on from that diagnosis and
at the moment his cancer is completely undetectable, no signs of cancer whatsoever in his body, me triplet
therapies, chemo, hormonotherapy and had a novel hormone, but his case asks us all sorts of questions
that we've never had to answer before. So, history is on and his cancer is undefectable, is he
cured or is he only undetectable because he is on
hormonotherapy? And toes treatments have significant side effects. So I think in terms of where do we go next with this
research it is answering the questions, well, what happens if he has a treatment break? Does his cancer just come back, or has the treatment
done the job of ridding his body of cancer? For men who have incurable cancer we wouldn't treat
them radically, surgery or radiotherapy because the cancer has spread through their body but Kevin showed
me his scans, there's no sign of cancer in the rest of his body, so should we go back and do radical treatment
at this point and would that cure him? And I think, Kevin's very open about this, he exemplifies the
dilemmas, but also, the hope that we have in this space, where, you know, just a few years ago we would
be in a situation where, he had a very bleak future, and frankly a very short future and he's now in a
position where three years on from his diagnosis there's no sign of cancer and that's fantastic
progress. But it is where do we go next with this? How do with he do the research that tells us, what is
the long-term choices that are best for Kevin that enable him to stay healthy and well, reduce the burden
of side effects, get the treatment right for him? RICHARD: Fantastic. Lots of reasons to be really happy but so much still to
be done I guess. But, yeah, great. OK. Right where are we, Robin.
Sometimes I miss a question, so, right, so Bupa recently launched a new prevention pathway for breast
cancer, can you tell us more about this. ROBIN: What we have is something called the my
prevention plan, this helps people to understand their future health risks, including those that cover breast
cancer, diabetes and cardiovascular disease. So this is currently alluvialable within the UK insurance but
there are plans to expand that further, including to highly prevalent cancers, so, we're sharing more news
on that soon. So, watch this space. Now, just in terms of accessing that, so, people can
access that through My Bupa approximate, that's easy for them to engage and access support through the
channel. What the journey looks like, they start with preventative assessment through one of our Bupa Health
Centre, and during that, we consider fact to saytors such as family histories, there's a questionnaire -
another risk factors that we bring in to that assessment. Other additional investigations, may also be done, so,
such as genetic testing, and other such tests maybe recommended to clinically appropriate, the purpose of
that is to really build that rounded picture of the individual's risk.
And the next step is to have a review with a Bupa healthcare professional. They go through the results and explain what they mean,
and all of that helps to then, develop this personalised prevention plan. So, it is really focused on those practical actions the
individual can take, so we take them on the journey through those steps, the output of that maybe support
in one manner or another, whether it is health coaching, enhanced screening, it maybe referral to a
specialist is appropriate. Or maybe even offering preventative treatment or risk reducing surgery, so very much the whole suite of
outcomes depending on the individual's need. , now this forms part of the broader personalised
health offering, that includes the Medication Check which you've heard some examples of. And, so that is using farmo genetics, which is what
medications a person will or won't respond to, there's over a hundred medicationness that test.
Overall, for people, undergoing cancer treatment as we're discussing today can help the clinicians to make
informed prescribing decisions and really help influence that conversation between the doctor and the
patient. It helps optimise dosing, ultimately, it helps to optimise the outcome that everyone achieves.
RICHARD: The medication checks so good, isn't it, if you have cancer, I imagine, you've been through this,
enough to worry about it, and you don't want to worry about whether it is the right drug or not this is to
help you to cut to the chase. By the way, anyone worried about the fire alarm, it was a test. So that's
why we didn't run. Cool. OK. So, Carly, I will come to you, so from your experience
what was the most difficult to navigate while living and working with cancer and what do you think employers
need to better understand to make a real difference. CARLY: Given my personality I'm just get on with it
type of person, I'm very aware that a lot of people are not like me, everyone kept saying to me, why are you
OK, why are you so, have haven't you cried or got angry, that's me as a person, so I think from employer
perspective it is about understanding and knowing your team, as a big one because not everybody will react to
cancer diagnosis as you would expect. Everyone was quite, I think secretly thinking I was have a massive nervous break down because I had it so
together from the outside, that's me as an individual and that's how I am. From employer perspective it is about listening, and
understanding their employee and personalising their approach, we talk about medication personalised but as people manager and colleagues, it is about obviously
just asking the question, what is it you need, what can I help with, and what else can we do to support you?
I obviously worked for quite a significant period of time throughout my treatment, I was really fortunate
that work were flexible and I appreciate in some organisations that might not be possible or certain
roles, if employers can give more flexibility around appointments and things like that as well up to the
diagnosis and during the treatment, I did have a period of time off, so I think it is important to have a
recognised sickness absence policy as well so as an individual you're not having to worry about the money
situation at home or things like that, which is a big thing. And I think, that some organisations really need to
look at the sick absence policy and say, does one size fit all with that, I don't think it should with
long-term sickness, particularly cancer. As I've said my journey was really relatively quick I think coming in and out, I was off for three months,
which from diagnosis to all treatments is quite quick. Had I have to have chemotherapy it might have looked
different. I was supported well with a phaseds return to work. As well and I think one of the big things for me, it is
something I'll be honest, I've not identified myself is having cancer and treatment following cancer doesn't
stop the day it finishes, I Finchished in the mid-of January and had further surgeries and even I get taken
aback sometimes by the side effects that present. I mentioned to Amy, I was sat on a call the other day
and I got this fatigue that come over me, and I didn't recognise it it was a side effect of cancer, because
I'm get on with it, if I can't, how can my employer understand it. So, again, it is having that open conversation to be
able to say, I said so my boss, oh I just need half an hour, I'm going to take half an hour, have a snooze and
go back to work, so, again it is that personalisation and one size doesn't fit all.
We are seeing it more increasingly in workplaces diagnosis of cancer and people living and working with
cancer for much longer, so I think the biggest thing is, about personalisation, listening, and having the
flexibility with your employee to support them as much as you can, and I feel I'm very fortunate.
If we can't have it from Bupa, who are helping people
living happier healthy lives, who can, ask the question, not everyone is going to be like me.
RICHARD: We talked about doing medically, but it is about the leader, knowing their people, working with
their people and being flexible and making it the best possible environment for that situation.
CARLY: Absolutely. RICHARD: That's for free. OK. Robin as new break through cancers drugs and treatment
continue to emerge how is Bupa providing access to this to customers.
ROBIN: One thing we have in Bupa is our cancer promise. Which effectively means that cancer treatment
is available for as long as it is clinically appropriate to be offered to the individual. What that means is there's no financial limits or time
restriction, and people can continue to have that care provided by those recommended, consultants and
facilities that are within our networks. I think, ultimately the crux of this is that the care
that people can have, it is funded by the clinical appropriateness, rather than being time-bound or
cost-bound so it is very much down to do you need treatment? Yes or no for your cancer.
In terms of access to those breakthrough cancer treatments, that's also, included as well within that
cancer promise. I think, a good example of this is Chemosaturation, this is where you isolate the drug supply to an
organise an and saturate that with chemotherapyo therapy to build up the density of the drug in the
orphan to treat it, that's often done with organisance like the liver, that's an example of something we would
fund because actually it is evidence-based and so the data behind that, shows one year survival for having
that treatment, increases from 25 to 60%, yes we have the cancer promise and actually we're very willing to
fund those treatments where there's a good evidence base behind it and it is good clinical practice to do
so. RICHARD: Thorougher we're very proud of the cancer promise, it is we've done for a long time.
Amy, coming to you what, are the biggest barriers preventing earlier diagnosis today and where can
employers realistically help. AMY: So I think we said it a few times but it is worth saying again.
The earlier you diagnose prostate cancer the easier it is to treat.
What makes that tricky is most men in the early stages there aren't no symptoms. So, what we need is minute to understand risk factors,
that's about age, family history, about ethnicity so black men have double the risk of other men, one in
four black men will be diagnosed with prostate cancer in their lifetime, prostate cancer UK have online risk
checker. It is used by over five million men so far. And it is about giving people that personalised
information about their level of risk but crucially if you are aat higher risk, what can you do about it, what
are the tests how do they work and what reality pros and cons of having those tests.
So, think in terms of what is the role from employers,
simpliest ease EY thing is share the prostate cancer concertain UK risk checker with workforce.
If you want to do something more interactive a bit more getting your staff involved, prostate cancer UK happy
to have conversations about doing awareness talks and webinars, and doing stands, you know, we really want
the population to understand their risk of prostate cancer and to be able to make informed choices about
whether or not they want testing. Because, at the moment, within UK we don't have
screening for prostate cancer so it is not like the other big cancers, breast cancer, lung cancer, bowl
cancer, where you get an invitation for testing with prostate cancer it is all about you as an individual,
understanding your risk, and having that conversation with your GP. So we want to help people to understand that.
And to have the information they need to make the choices that are right for them. RICHARD: Thank you.
The risk checker is great, I'd encourage everyone to use it. I'm interested how often should you get checked.
AMY: That is the million dollar question. At the moment, the evidence is not entirely clear about
this. But what we do know is that annually is probably
plenty. As in I know that some people you know, get to a point where they feel like they need to do a test every six
months. Prostate cancer relatively slow growing disease and any more than annually is excessive.
It does vary, that's what makes it difficult, so if you have more risk factors, if you have a close family
history, if your dad or brother, has had prostate cancer, particularly if you have a family member who
died from prostate cancer, then you're more at risk of more aggressive disease, so for those men, absolutely
annual test from mid-40s, would be a good idea. If you've no family history, if you're not a black man,
then probably every couple of years is fine. But at the moment, the evidence, unfortunately is not
crystal clear on intervals. RICHARD: Great thank you very much. Robin, coming back to you, could you talk us through
the other cancer services available to customers under UK and global PMI policies.
ROBIN: I'll split this out for those available to both UK and BG and then the others separately.
So, for customers on both policies, so firstly our cancer specialist centres, we got those cover bowl,
breast, gynaecologist and the really good things pathways and centres themselves is the speed and the
rapid access to the diagnosis and the treatment. So, it is a really slick process, well trodden path of
getting people in there and tested. So, it is typically a one stop assessment so it helps
with driving that efficiency and hopefully for most people providing quick reassurance. The second thing
is skin analytics, remote skin assessment service, so for people who have concerning moles or skin lesions
that's using Smartphone clinically validated AI, so again, customers can get really fast and convenient
access to assessment of their skin lesion where they're worried about that and escalation to specialist if
needed. That service is currently UK specific but we are exploring how we can make that available for more
global customers. And, other UK, insurance specific services, so direct access, so, important thing about that is you don't
need a referral from your GP in order to make contact with the service so it is really reducing bearier to
entry to the healthcare pathway. Employees can speak to trained advisor about symptoms
and if there's concern that is cancer related they can be referred immediately in the pathway and typically
they can see someone within six days. We have avenue got support services for customers,
during and African certain treatment, that includes Anytime HealthLine as well as our living well with
cancer service. And, you, people go through a range of motions when they're going through a cancer scare or cancer journey,
so having those services help and support people and help them move forward and get the advice and support
they need. And on the IPMI side, people global, we've got the
second medical opinion service. So, that is company . help facilitate second opinion via international
specialists that's particularly useful when they're casing a cancer diagnosis or tricky treatment decisions
that they're working through. We've got the global virtual care, a service for virtual consultations which people can able syces
through members world, really helping people access medical advice wherever they are in the world and
clinically led care coordination, it can be difficult knowing how to navigate the healthcare system,
particularly when you're looking at it on a global level, that's important not just supporting the
individual but helping them get to the next stages of care and get the best outcome for them.
And I think the final point being, across the global network we have more than 2.1 million method canning
worldwide so we have the access point as well. Overalls there a great suite of tools and resources
there, regardless whether you are on BG or UK policy. RICHARD: Health assessments, all sorts of stuff in the
early detection space as well. Thank you very much. I've last question for all of you, and then we're going
to come to another poll and open up to questions. If you have questions get them in now.
Right. Come to you first Carly, finally to end our session I'd like to ask each one of you if we're having this
conversation again 20345 what would you hope had fundamentally change with the cancer diagnosis and
care. CARLY: I'd like to see a big focus on greater prevention and early diagnosis as one.
Wider genomic testing options, obviously that impacted me massively with my journey.
And then timely I'd like to see advances in cancer access, being equal across the NHS and private.
There is a misconception the NHS you won't be able to get the treatment you can.
Privilege medical space gives us access to that, but I'd like to see that across every aspect because people
are touched by cancer all over, so it would be great to have equity in the cancer pathways.
RICHARD: Thank you very much. Amy how about you enthusiasm AMY: For me I think it is a fundamental shift to think about harm reduction when
we talk about cancer. So, I think, for generations cancer has been such a
terrifying thing that our culture has been securitiable all costs and costs of cancer treatments can really
high and significant impacts on people's ability to live the lives they want to live, often for decades.
And I think as we get better at understanding the different ways that different cancers behave, we find
more and different ways to cure those more aggressive cancers. I would like us to get to a point where we're
talking about best treatments. When we talk about best treatments what we mean is the best balance of saving lives, but also saving quality
of life. And I think, I think it is a really big culture shift that actually as a whole society we have
to go through because I think when you're sat in that waiting room, or sat in that consulting room, and you
hear the word "Cancer " we know from the thousands of conversations that we have with men and their loved
ones, the instinction is get it out, let's treat it, I just need this gone. But actually, how do we become much more personalised
in our approach so that we're getting everyone the best
outcome, rather than just a focus on curial costs.
ROBIN: Continuing that journey to the earliest possible stage of detection, detecting it early, detecting
using, the best treatments and diagnostic and then treatments and doing those treatments on a very
personalised basis to achieve those best outcomes, very much using the newly developed tools and techniques at
our finger tips. RICHARD: It is here now, isn't it. Doing more.
thank you very much. By the way the first poll, what was it does
organisation poi supports services for those affected cancer, 80% yes, 20% no. So, a Hoy proportion which is good.
Right questions from the audience now, Carly, come to you first. What kind of support had the greatest impact on you
during your cancer journey. CARLY: , I think from, I'll do it twofold, there was I
think the friends and family are a massive support. But, I think the biggest support for me, which might
sound really weird is comforted I had in private medical insurance so I knew I was getting the best
treatment possible because I could help inform the outcome of that. So the fact I had great clinicians I could choose my
clinician and read about them before I got them, I wasn't just given a consultant, I felt it was my
choice, so for me that gave me the biggest support knowing that I got listened to. And that my choices were heard and actually I could try
and impact my outcome and it gave me real peace of minds to know I had the best people in my corner and
continue to have, so that was the probably the biggest support, friends and family were there they're amazing
but the clinical side was the most comfort blanket to know I'm in the best hands really.
RICHARD: Thank you very much. Robin, I think I have one for you next. So, cancer care isn't the same in every market and
location, how does Bupa help customers help the right treatment dying no, sir sincere and support when they
need it. ROBIN: , so the first point is about it needs to be
evidence-based, so we also know guidelines, licensing, varies across jurisdictions so there is inconsistency,
so, where possible, we try and look at someone's cancer care and options according to what is locally available
and what is best practice. Now because of the difference in jurisdictions, sometimes there maybe a need to either try and get the
treatment to the individual, or the individual to the treatment. That's more relevant for someone working, living
globally on a global policy. But yes, within a UK-based product, it is very much
about trying to bring the treatment to the individual, making things eligible, and working out have we a
partner that can provide that for us. So, really, navigating the healthcare system for the
benefit of the individual. RICHARD: This one to both Robin and Amy, we had one
saying, can my GAPDH decline PSA test for prostate cancer do I need systems or being in the risk category
enough to request. AMY: That's the million dollar question because there has been quite a lot of confusion around this and a lot
of headlines of suggestedded the policy has changed. The Department of Health have been very clear, that the
policy has not changed. So, if you have concerns about your risk of prostate
cancer you can go and speak to your GP, and your GP, you have a right to a PSA test from your GP, this GP
will ask for symptoms and history, any other things that might mean that the PSA result might be
interpreted differently it is important to have an honest conversation with your GP about that, we've
heard from a few different places there's fear that GPs might refuse testing so a suggestion that you need to
lie to your gap and lie about your symptoms, do not do that, because at that point you might be getting
unhelpful or inaccurate medical advice because it is based on wrong information. But no, absolutely not, within the NHS you are entitled
to a PSA blood test, just have a conversation with your GP about it.
RICHARD: Thank you very much. And, probably our last question today, back to you Amy, I know you answered this but it is worth saying it
again, so I will ask you again, is there anything that employers can do to support early identification of
cancer and prostate cancer? AMY: I think really making sure that people understand their risks, so promoting the prostate cancer UK Online
risk checker, but also, you know, it is practical things I can like if you need to have a GP appointment
to discuss the PSA test, making sure there's the Flex within your working policies so people can go and NEW
SPEAKER: medical appointments. One of the things we see very clearly in the data, is that there is a
difference in how likely you are to be diagnosed at a late stage. And if you are from an area of deprivation
you are more likely to be diagnosed when your cancer has spread, and one factor is less ability to say, I'm
going to be in a bit late because I'll pop to the GP. Actually those sorts of things can be absolutely
life-saving and making sure you have those adaptation source that people can go and seek, routine medical
care within their, because, we know that the NHS, get ago GP appointment is not always the most
straightforward thing, you don't always choose to have the 8am or 6pm appointment that fits neatly around
working life. So that Flex for staff to be able to seek healthcare, I
think is really important. RICHARD: Great thank you very much. Massive thank you to all of my panel today, it has been
a really good discussion so thank you. The thing I've taken out of it, Bupa can help you with
loads of stuff but actually more than that as a leader there's loads you can do to your employers by knowing
them well, be Flexbling and creating the opportunity to get tested or if they're unlucky enough to have cancer
to navigate that as parliament of the business. Thank you for all of you to answering the questions and
bringing it to life today. Before I do the outtrough, go and get tested this is my
Bob Geldof moment, go and get tested and better to know early.
OK, we've had a great discussion today, about how cancer prevention, diagnosis and care are evolving and
what these changes could mean for employers and their people. Thank you to all our speakers for sharing your
insights. As always, don't forget to keep an eye out for our
follow up e-mail, it will have been valuable resources in it and this Movember, to help employers to help
conversation with talk and talk November challenge, for every Walk & Talk, Bupa had donate £10 up to pods
10,000. If you want to get involved, speak to account manager to get involved in that today.
, thank you for joining us today. We'll be back with Health Horizons in the knew year,
stay tuned for that, I will, I can't say happy Christmas but have a great time, we won't be back until
after that. Look forward to seeing you again soon.
Dive deeper into key themes from our latest event
Cancer Care Reimagined: Early Detection and Personalised Support
Employers have a unique opportunity to support earlier intervention, improve employee outcomes and develop more proactive approaches to prevention and care.
About Health Horizons
Understand the trends
Our experts identify emerging trends early, so you can prepare your business for change.
Turn ideas into practical steps
Take away simple, actionable advice you can implement into your workplace.
Make informed decisions
Use clear, evidence-led guidance to shape your workplace health strategy in the long term.
Who should attend our events?
Business decision makers
Anyone making business decisions, including senior leaders and day-to-day managers.
People professionals
Anyone involved in the people side of business. For example, HR professionals, talent acquisition and wellbeing benefit managers.
Watch our previous events
Catch up on our previous discussions with industry experts, innovators, and thought leaders.
The current mental health landscape and the sandwich generation Good morning everyone and welcome back to Health Horizons.
It's great to have you with us.
Today we'll be discussing the rising mental health pressures in today's workforce and why these are being felt most acutely by the sandwich generation.
The sandwich generation is defined as employees balancing care for both children and aging parents alongside their jobs.
Let's start by highlighting why we think this topic should be a priority for all businesses.
68% of employees experience burnout while 73% struggle with work rellated stress.
Around 1.4 million people in the UK are sandwich carers.
53% of sandwich carers reported that they were unable to work at all or as much as they would like.
These stats demonstrate why supporting employee mental well-being really matters.
Especially for sandwich carers who are a workforce group facing some of the most intense mental health pressures today.
As longer life expectancy and later parenthood increasingly overlap, more employees are finding themselves in this sandwich position.
Research shows this strain drives declining mental health and physical health as well, creating hidden business costs through loss of productivity and increased absence.
This is a challenge businesses and healthcare partners must address together with a stronger focus on early intervention and prevention, helping employees access support sooner rather than later.
So, let's meet our expert speakers today.
I'm delighted to be joined by Sher King, founder and director of Sandwich Generation Support.
Welcome, Sher.
Um, Sher is a former senior NHS leader and experience coach who draws on both professional and lived experience to help organizations support sandwich generation employees.
We also have Rian Blake Blakeley, mental health clinician lead at Ber.
Morning, Rihanna.
uh and uh she is a cognitive behavioral therapist with 15 years experience in mental health field and currently the mental health clinical lead for booper's remote mental health service and also Dan co-founder and CEO at Jack uh Dan co-founded Jack or just ask a question a ber partner and in innovative online platform which provides mental health support in a unique and interactive way Dan we'll hear more about Jack from Dan later on in the session as always please send us your questions throughout the session and We'll answer as many as we can a little bit later on.
Uh you also love love love those uh brilliant polls we have.
So get ready for those.
We'll have some of those coming up uh later on.
Lots to get through.
So let's get started.
I'm coming to you Rian first.
So um let's start with the bigger picture on mental health.
Latest research shows that stress, anxiety, and depression now account for over half of all work rellated ill health in the UK.
What has changed in the last few years that has intensified mental health pressures across the workforce?
Yeah, thank you.
So I think all of us, every one of us will bring everyday kind of stress and the pressure outside of work into work and a lot has changed for us over the last few years which of course will have you know added to the pressure of the mental health of our workforce and for example many of us will be worrying about the the rising cost of living currently and you know alongside the wider worries about the uh social economic and climate factors that are going on and all of this is going to be adding to to our stress.
You I think one of the the big changes that we had over the last few years with the pandemic that we all had to navigate that uncertainty and the way that we've worked has changed since then with much more of us working in that hybrid way.
So many more of us working from home now.
And whilst there, you know, tons of positives with that, that absolutely can be those unintended consequences, the blurring of the boundaries between work and home life.
You know, how easy is it to jump on the computer and check your emails late in the evening?
So, does it make it harder to switch off?
That can then be added to our stress.
You know, another change that we've seen are the advancements in AI and tech over the last few years.
Again, loads of positives here, but actually could that be increasing the worry and stress?
Are we worrying about the job security and actually the pace of this as well?
These advancements that really fast pace, you know, having to navigate this um change changing the way that we work adding to that stress in the workplace.
So, we can see all of those factors just mentioned there will will shape how work is experience how stress is experienced in the workplace.
And as you mentioned before, your mental health is now the leading cause of work rellated ill health in the UK and 73 of employee percent of employees report struggling with stress and this just highlights you know how widely spread the problem is here.
You know on top of that other research shows that the average absence levels have increased and they've gone to 9.4 days per employee per year and represent 62% of all working days lost.
This is reflected at what we're seeing at BER.
So in 2025 alone, we had over 25,000 customers access our mental health service.
So of course when people are not feeling good in terms of their mental health, it is going to affect work, the productivity, increased absences unless our staff get the right support and help that they need.
Another fact I just want to mention is that I do think the awareness of mental health at work has definitely increased through the last few years which is great but perhaps there is a gap between that awareness and the practical support that's given.
For example, there's enough time or training given to managers to be able to offer that practical valuable support to to staff.
So we can really see that over the years you know stress has built up.
There's lots of things that have happened, lots of things that are still happening and maybe we don't get enough time to recover and rest between those factors.
So that's why we can see that you mental health is overtaking the physical conditions is that that leading cause of of absence at work and the implications are clear.
You know this absolutely needs our focus.
Mental health is now a core health place risk here and it needs to be addressed with the same focus um that that serious nature as we do.
It's physical safety at work.
Yeah.
Yeah.
Yeah.
It's uh quite scary the acceleration, isn't it?
And absolutely.
Um it strikes me as well, we talk about this quite a lot on Health Horizons, but leadership comes into this in a really big way because you know people aren't going to park their challenges at the door, are they?
So knowing the situation your employees are in, knowing that they have children or an elderly parent they're caring for as well and making the adjustments is so important to uh to make sure the environment is right.
Dan, I'm going to come to you next.
So why is early intervention and prevention so critical for employee outcomes, engagement, and long-term well-being?
I think similar to Rian, the the headlines are pretty stark.
So there's 22 million uh days lost to mental health absence.
Um but I think even even sort of more stark to that it's a 24% increase year on year.
I think all the reasons there that Ron you you provided is just this macro compounding effect uh that's then playing out in in absences and then a you can see a really incre a sharp increase year on year but there's some really super interesting data that's starting to come out now that I think we haven't quite captured or or or properly understood yet.
So there's some research um run recently at the University of Queensland actually in Australia but it's a global piece of research because 23,000 global workers over two decades.
What that's starting to see is individuals are getting worse over time and cohorts entering into the workforce arriving with a lower base point of mental health than previous generations.
So if you look at those workforces that coming in their 20s, actually their base point of mental health is actually poorer and that's having a compounding effect because people are taking um more u mental health absences for longer and often the complexity of those is increasing year on year which is having a compounding effect within organizations.
So, I think we've really got to start to to um have an increased focus of those emerging work forces that are coming into the work workforce in the 20s because we can't ignore them.
They are our most important generation within work.
Yeah, sure.
And what do we mean by base point?
Does that mean they're like less resilient or less prepared to start with or presenting later or Yeah, I mean I I think you could use the term resilience.
I think that that's been a term that's been used particularly I think in the last 5 years in a workplace um um setting.
I think it's probably becoming slightly more unpopular at times in in in workforces.
So I think there is an element of resilience but I think it it plays into everything that Rian's said there.
If you think uh younger generations have been through co while while studying you have this this macro but intense environment of how we consume content.
we have so much more technology that's that's that we are much more present and engaged with economic geopolitic.
So there's all of these I think contributing factors that are bringing workforces in.
But I think also it's it's it's worth noting I think organizations are doing a really great job at making at breaking the stigma.
So actually we have safer spaces that we're able to start to be able to talk to colleagues or to your point earlier Richard leadership teams um to actually make make this um less of a taboo subject.
Yeah great thank you very much.
Uh so Sher coming to you as I mentioned earlier you're part of the sandwich generation yourself.
Can you tell us a bit about your story and how does juggling work, children and caring responsibilities affect mental well-being and performance at work?
Yeah.
So, um I'm an NHS manager by background for 21 years and I work nationally, regionally, and locally.
And I'm also a coach as part of that.
And then in 2019, my mom was diagnosed with Alzheimer's.
And at the time, I'd got three children under six, a full-time national job in the NHS and also trying to support her.
And to say it was tough is an understatement.
And I reached out for support and was basically told because I wasn't the main carer, which was my dad, that there was nothing there for me as a sandwich carer.
So I felt very unseen, unheard, and it just really put something inside me.
So sadly, my mom passed away at the end of 2022 and I decided to do something about it.
Um, so I set up sandwich generation support and I now work with um employees to who are in the sandwich generation to really see that they're recognized and to raise that awareness and to support managers to make sure that they're um able to support as well.
So yeah, as we talked about earlier, the sandwich generation is people who are caring for parents and then um they're in the middle and they also might have children as well.
And it's so prevalent now in the workplace, you know, it's it's one in five employees.
And when you just imagine your teams and everybody, you know, even where we are today, you know, it it's crazy, isn't it?
How many people it actually impacts and the impact on mental health for people in the sandwich generation is huge.
You know, it's um so many people I work with describe this thing of being everything to everybody where you just you're just pulled in all directions and you just can't do everything.
you're a parent, you're a daughter or son, you're a, you know, you're an employee, everything else.
And it's just overwhelming and lots of feelings of guilt as well.
And then in terms of organizations, this shows up in terms of presenteism, in terms of retention, all those kind of things.
And um actually 600 people leave their job every day due to caring responsibilities, which is just crazy when you think about that.
It's so so many people.
So it's such a big thing to be juggling all of those things.
Yeah.
Absolutely.
And it sounds like a really tough situation.
Yeah.
Alongside that from a business perspective, you know, if you're losing people and really good people because, you know, they they can't manage everything, that's that's not good either.
Rian, I know you're in a similar situation.
Is there anything you'd like to add?
Yeah, I can really relate to what Sher just shared there and, you know, was connecting it to my own experience of of being in this generation of having young children that I look after, aging parents as well.
Um, and the thing that springs to mind for me and it's been talked about already here is at the workplace being able to talk about it and feeling supported has been really really important and it kind of works on two parts.
Obviously comes from me to feel comfortable and safe to be able to talk about it to my manager but also feeling heard as well and that's made a real difference for me.
Yeah, absolutely.
And it's you know line manager plays such a role in creating a safe environment for everyone to be able to have those conversations.
um and then you know go on to make those adjustments.
And I mean I I my situation is not nearly as um tough as that.
But it's hard enough with my eldest has just got a mobile phone age 13.
That's pretty scary.
And then I've got my mom going should I have clicked on this link?
It's like well maybe you should just join up and have a conversation.
But I mean you know from a brain perspective it's um yeah anyway right we digress.
Uh so Rian, clinically, how do mental health uh the mental health challenges faced by sandwich carers differ from those experienced by other groups in the workforce?
So we've been hearing about the sandwich generation.
So those that are in paid employment, the balancing caring responsibilities for the young children, aging parents or relatives and being at work as well.
And the first thing that comes to mind are the competing and often unpredictable demands on their time.
And I always say care doesn't necessarily run to a schedule for example unexpected hospital appointments.
You get the phone call from school.
There are school issues.
Your child's poorly.
You need to come and pick them up.
You're in the middle of a meeting.
Yes.
So it doesn't always run to schedule.
So having rigid working conditions are just not sustainable here for those with the caring responsibilities.
And I really want to stress that it's not about lack of commitment or that motivation at work.
It's about capacity.
So those with the caring responsibilities, the cognitive, so the thinky load, the emotional toll is so so much.
You think before they've even logged on for work, how many decisions they may have had to have made before they've even logged on, you know, and and these care and responsibilities and that sustained load over time can show up as chronic stress and that exhaustion.
it becomes harder to recover because those responsibilities remain and it can leave us vulnerable to the experience of low mood, anxiety and burnout.
You know, adding into the mix here financial worries.
So, supporting two generations at the same time is costly.
You know, we mentioned before about those rising costs of living.
So, those money worries can play a real part in terms of that stress experienced here by our sandwich carers.
Another key issue, I kind of touched upon it a little bit before, was is around visibility.
So you may find that those with the care and responsibilities might not want to disclose what's going on for them.
Perhaps they feel it's too personal to disclose or they're worried about how it will be received judgment.
Will it have any, you know, consequences for them?
So they may continue to struggle quietly.
And as employers though, that there could be signs that we can look out for.
So perhaps a reduction in availability, focus, energy, you know, potentially we could misread this as disengagement, but actually these could be real signs of that burden and that overload that's going on for those with the caring responsibilities.
Another point to make is about the career impact.
So again, people in this generation, they might not go for the promotions or the leadership roles or they might step down.
just the thought of going for a role, the energy that that might take and the cost can just feel so high for them that they might not put themselves in those positions.
So actually what we can see is we've got the real kind of well-being issues and impact but also that workforce sustainability issue here with this generation.
Yeah, sure.
So really from ana from a uh uh sort of leadership perspective, it's really about knowing your team and being able to make those adjustments, but have those conversations where people want to.
Of course, you can't force people to have the conversation, but I think it probably helps if you know their situation to start with if they're willing to open up, doesn't it?
Absolutely.
Okay, great.
Thank you very much everyone.
That's been really interesting uh to hear how mental health landscape is evolving and what that means specifically for the sandwich generation.
It's clear there's a need for more targeted support for certain groups of the workforce, but also for all employees as we face more mental health pressures than ever before.
Uh right, we're going to move on, but before we do that, I know you've all Exploring support strategies, innovations and Bupa’s solutions been waiting for the poll.
So, do you feel your organization understands the mental health challenges faced by the sandwich generation?
Yes or no?
Uh and uh we'll tell you the results later.
Okay.
Okay, now for part two.
Uh for the next part of today's session, we'll look at the latest innovations and what employers can do to better support employee mental health.
We'll also explore the specific needs of the sandwich generation, which strategies can make the biggest difference, and how BER and Jack can support your employees.
Okay.
So, I'm going to come to you first, uh Dan.
Uh so for those uh who may not know uh who may not know it, can you explain what Jack is, how it supports uh employees mental health and how it fits into a preventative well-being strategy?
I certainly can.
Um so Jack stands for just ask a question.
Um we're very proud that we've been working with BER for over four years now.
Um, essentially we are an interactive digital uh preventative tool that provides access to a really safe space in a digital format and provides experts, doctors, those with lived experience on a real vast range of topics from uh addiction to depression to anxiety to to stress uh to sandwich carers, both lived experience and experts.
The list sort of goes on and on.
But essentially what it's trying to do is is three things.
It's trying to ensure that people stop seeking uh help earlier.
So it's breaking down stigma, it's breaking down access, and it's making sure people know where to go and when to go.
So we've used we've had quite a few I think occasions when we've been talking today that this platform was really built and designed for.
Um so we talked about those moments that that you could be a car and you don't know where to go.
Well, actually, it could be 11 o'clock at night that you you're in a moment by yourself.
You're not quite ready to put your hand up for an intervention yet, but you can go and find information.
You can speak to somebody that actually might be going through something similar to yourself and then revert to an expert to try and get some really credible information that that that sits behind it.
So we sit firmly above the clinical stream and then we connect and we design journeys and pathways that provide people earlier intervention into design pathways that actually at the point of need when somebody does need a clinical intervention actually they can be rooted into a ber pathway um in a really sort of pre-esigned and governed way.
All of our content is clinically governed um it goes through a sort of raft of checks through booper and ourselves which we're really proud of.
Um and this year sort of a marquee moment for us.
So jacket work is now available across 1.5 million lives across the ber book.
Um which is is a sort of an increase year on year that we're providing this service uh to booper customers and more so it's the first time that we've actually integrated and launched acrossme book.
Great.
It's a core part of our our proposition I think.
So uh cool.
Okay.
So Sher, from your perspective, what support does sandwich carers really need to help manage their mental health while working?
So I'm going to share a story first of all of somebody I've been working with who's given me permission to share this called Aisha.
So her husband is a shift worker.
So he leaves the house at half 5 in the morning.
And her mom lives with her who has early onset dementia and she's got two children as well, one in primary school and one in high school.
So, in that morning, he's gone to work.
She's already made packed lunches.
She's helped her mom get up and get dressed because she's unable to do that.
Um, she's also helped her mom um and reassured her with emotional things like I think her mom had believed that her own parents were coming back.
Um, that kind of thing.
Um, and then the WhatsApp parents group is ringing all the time, pinging all the time because it's the um the familiar thing of it's a school trip date which she'd forgotten about.
So all those kind of things going on and then the kids have gone to school.
She's taken them to school.
The carer has come to support her mom and at that moment she logs on.
Nobody at all in work knows at all that this is going on.
And this is just the impact of her story.
There are so so many people like that.
And one of the things I think the first reason she doesn't feel that she's able to say anything is due to she doesn't feel psychologically safe.
she doesn't feel and she doesn't think that people will understand because they're not aware.
So I think the first thing around um how we support sandwich carers is very much making sure that organizations have got that psychological safety and that awareness is there.
And again, I've worked with a chief exec um in a caring or organization who herself was a sandwich carer and didn't say anything because she she didn't want to, but then she did eventually.
And the difference that that's made by her speaking up and being so vocal to um sandwich care and mental health within her organization has been massive and other people have spoken as well.
So I think the second thing to think around sorry it can't go um with supporting sandwich carers mental health is around compassionate managers and I know we've we've touched on this already but managers make such a difference and again if you're you know it's 70% of people say that their manager um makes more of a difference to their mental health than the GP and their partner.
So it's a massive thing here.
So making sure that managers are equipped and able to have those conversations.
And I think the last thing that sort of makes a real difference to sandwich generation mental health in the workplace um is around that practical support and flexibility and I don't just mean like your policies you know have you got your flexible working have you got this what actually is that like in practice what does it feel like you know and as Rian said you know what happens and this happened to me I was in a board meeting and my dad's number flashed up on the screen what do you do you feel you're able to leave do you go you know really important NHS meeting it was like that moment Um and it's just having that flexibility and that understanding and everything together will make such a difference to the mental health um of the workplace.
Great.
Thank you.
So um create psychologically safe environment.
Um leaders role modeling so important in many of the things we talk about isn't it?
Because that kind of makes it okay if it needs to be made okay.
And then the flexibility building the flexibility.
Cool.
Great.
Okay.
So Rian, in your experience, what preventative measures truly make the biggest difference when it comes to employee mental health?
So quite similar to what what Sher's just shared there, um, and I will touch on some of those points, but the evidence on workplace mental health is that prevention works best when an organization is proactive with their measures and not just reactive to those individual support needs.
Is preventative measures are key and focusing on that.
And, you know, let's just think about the factors that can add to stress.
We've touched upon it today, but we know the factors like excessive workload, that lack of control, poor role clarity, job insecurity, insufficient support.
Now, these don't just worsen existing mental health problems.
They can actually actively contribute to the development of things like anxiety, depression, and burnout.
So, you know, preventative action starts here.
And evidence shows that if you increase employees sense of control over how and when they complete their work, this has a real kind of protective effect on mental health.
It means giving people predictability, that flexibility, trust to be able to to work you and we talked before about those demands on time.
They can be unpredictable, not scheduled.
So having that sense of control is really really important.
Flexible working.
And Sher mentioned this as well is another area where the evidence is very clear that flexibility improves mental health of our our staff with caring responsibilities.
It can really help when you've got those work home life conflicts again those competing demands and it can again give people that predictability but it's important to stress here it that that flexibility it's not to be fragile or constantly renegotiated because actually that could contribute to stress if um if that's happening.
The big one for me and it's been a theme throughout our discussion here, psychological safety and it's so so important.
It's one of the strongest predictors of that positive mental health at work.
So what does this actually mean in work in the work environment?
So, it's creating that safe space that employees feel comfortable to be able to disclose how they're feeling, to share their worries, to set boundaries as well without that fear, that fear that it's going to be judged negatively or um there'll be kind of a negative consequence to it.
And managers being able to act upon that.
So, reasonable adjustments can be made so people feel listened to and validated is incredibly important here.
And that's certainly been the case for me of being able to feel safe to talk up.
I've had that experience of being in a meeting and I get the phone call and it's from school, you know, with the children poorly and it's it feels great to be able to just say to my colleagues at school, no problem.
Yeah.
It feels it feels really, you know, safe to do that.
Um so we can see, you know, mental health in the workplace, it's not a nice to have an optional add-on, well-being add-on.
is so so important.
These preventative measures are key here and I do think the same principles apply as physical safety at work.
So with mental health, we should be identifying the risks, trying to reduce the exposure to the stresses and always monitor and evaluate the impact of our preventative measures with our staff.
Feels like um a lot of it is I want to say common sense really, is it?
I mean, how would anybody feel if their parent or child was ringing, needed some help?
I mean, I can't believe many people would go, "No, don't go and take the call." But but knowing you can and creating environment to make that okay and is so important, isn't it?
Yeah.
Um Dan, I'm going to come to you next.
So research shows that for every one pound spent on mental health support, businesses can see a 4 pound return in productivity.
From your experience with Jack, what other benefits can organizations observe as a result of supporting employees with preventative tools?
Yeah, I I think I think that [clears throat] stat's um quite well known now, isn't it?
The the sort of five pound investment um uh or sorry return from a one pound uh investment.
So I think that becomes your sort of downstream so your macro financial.
Um I don't think that actually takes into account the downstream PMI cost reduction or preventative um element to it.
But I think this really is broken down to to three main areas um for me um that are all um I think key components for an organizational to be able to to to build into their well-being strategies.
The first is retention.
So there's plenty of research out there now that's showing employees with a high psychological distress are 1.6 times more likely to leave within a year.
So that's quite staggering.
So again, I think all of these these uh both trends and tactics and strategies of of creating a space a culture a I think a leadership culture that allows uh employees to be able to be open but with policies that support that as well.
So I think there's being open is one thing but ensuring that the infrastructure and organization from a policy point of view um uh allows these strategies to be able to be implemented.
Um the second one is utilization um as a signal.
So um utilization [clears throat] across an ecosystems benefits and and um uh offerings for for an employee is super important.
So if you look at EAP, virtual GP, etc., etc.
A lot of the time they could be quite hidden within organizations.
So people don't actually have access or awareness about them.
So that's one thing that Jack really tries to to um build an infrastructure around organizations that we connect and we actually amplify those organizations whe whether that is uh my ber and and and bluer or whe that be a an EAP or a policy etc but making those much more much more accessible um and then I think the third is some really interesting data that's come out of the Gallup workforce report um recently and that's just about the expectation I think we now have as a workforce particularly with that younger generation coming in some of the data come out that shows 80% of the employees globally are disengaged.
So that's a real problem, a real problem that we need to we need to tackle with.
Um so I think aligning the expectations of an employee making sure that we create the safe spaces and the policies and the awareness particularly around topics like sandwich generation is is increasingly important.
And that doesn't stop there.
It goes into inclusivity into neurodeiversity and and and um so I think it's really important that we actually provide a setting that that meets employees expectations.
Great.
So, wrapping it all together into one.
I mean, it's pretty obvious, isn't it?
Make sure everyone can find it for starters.
But, but in doing that, making it front and center of how you're, you know, we're here to catch you if you need it.
Yeah.
It I mean, it sounds very obvious, but then you start to look at different um profiles of of work forces.
So, um there's often a term used which is the sort of hard to reach.
We try and sort of flip that on its head.
So it's not actually the hard to reach.
It's our job to be able to reach those whether that be a factory worker, somebody in branch, somebody on the road, uh a posty.
So um I think designing well-being strategies and programs that actually engage inclusively across the sort of different dynamics of and profiles of organizations is is super important.
Excellent.
And thank you.
Sorry, just getting some feedback live in real time.
Thank you very much, Dan.
Okay.
Uh, so, um, we're going back in time slightly, just in case you weren't ready for it.
So, uh, Sher, I'm going to come to you next.
Where do employers often get it wrong when supporting sandwich carers mental health and what should they be doing instead?
Okay, so I think it's brilliant when employers want to support sandwich carers.
It's absolutely amazing and I'm working with lots of amazing organizations who are starting to do things about it now.
But I think one of the big things that happens is people want to raise awareness.
Um, so yeah, which is great.
Uh, and absolutely the right thing to do.
But again, going back to that psychological safety stuff, every single session I've run, people have had a light bulb moment, at least one person with, "Oh gosh, that's me, that I'm actually a carer." So people just don't realize that, but once they do, it's then that bit of actually I realize it, but I don't feel psychologically safe to say anything.
So I think that's one of the big things that you need to organizations need to do psychological make sure that psychologically safe as well as raising awareness.
So a combined approach rather than just the awareness sessions I think is really important.
I think another thing that one of the things organizations do is put lots of posters up of are you a carer and actually the language that people are using I personally didn't recognize myself as a carer.
I was googling, you know, people who were juggling this and that and all the rest of it and so many people I work with don't recognize the word carer.
So, it's really important to use a variety of language um when organizations are supporting employees because it's really really important to help them to recognize themselves.
And I think the third thing is around managers avoiding conversations, you know, and so many manager training sessions I run, they're like, I can't I dare say anything.
either I'm frightened the person's going to cry or I don't know what the policies are and I I feel overwhelmed.
So I just I just ignore I can see something's going on but I ignore it.
So I think there's something there around just making sure that people and managers feel able to say and are equipped to be able to have that conversation.
I think you've got to do so you've got to raise the awareness with in a psychologically safe environment using the right language and make sure your managers are trained so that they're able to then respond to that appropriately.
Yeah, that last point is so important, isn't it?
And many leaders or managers are often scared of having the conversation about a range of subjects actually because they're not quite sure, but actually, you know, it's best just to open it up.
You It's okay to say it's you don't know what the answer is and come away, but it's better to actually start the conversation, isn't it?
I can give you a live example that we had recently actually.
It was from from an employee in in Ber that's had Jacket work access for for quite some time.
um and uh they had a team member um that was going through a transition.
So it was they were uh uh within a sort of trans transgender conversation and the manager at the time didn't know how to approach that conversation, be informed, equip um because there's lots of sensitivities around what to say, what not to say to make sure that you are being supportive.
Um, so they found the information on Jack through a a video conversation and they used that to be able to both provide them confidence but also provide them that space that they could equip in a conversation.
It's exactly the same for a for a sandwich carer.
Um, I think the more informed we can be as leaders and managers um to equip ourselves with those conversations that is only going to have a downstream effect on on a wider population.
Yeah, I agree.
Not having the conversation is probably the worst thing you can do.
So yeah.
Okay, great thing.
I'm going to stick with you Dan though so you're not off the hook.
So, uh, we know mental health accounts for a significant proportion of claims and the tools like Jack can be most effective when employees engage with them early.
What evidence are you seeing at Jack that shows prevention leads to better outcomes and helps organizations manage mental health related claims?
Yeah.
Um, so I'd want to touch on this from a few different angles.
Um I think from a from a business leader, business owners, um that that's obviously going to start to see some financial impacts by implementing preventative measures.
And then latterly, I do want to touch it from a almost like qualitative, uh uh measure.
So what are we hearing from from users and the impact that it's having on on their life um with some some some really sort of powerful life stories that that it's impacted.
So we're starting to see some really encouraging data now that's coming through from our clients from 20 uh 25, so last year.
Um so organizations that ran Jack um throughout the year are starting to be able to see real business outcomes that we're able to measure.
Um and that's through their claims uh values.
So not volumes but values.
Um and the large proportion of that is due to by providing a space and an intervention earlier on and then rooting people to costefficient pathways earlier rather than waiting 6 months or into crisis or when complexities start to raise um um and become increasingly uh um more tricky to be able to structure someone into the right pathway.
We're now starting to see really strong signals that we're reducing those uh claims costs by pre-esigning the journeys.
Um, so we've still got some more data to be able to really put that into an evidence pack, but I think the early signs, um, which shouldn't really be a surprise to us to be honest.
I think if you are able to engage people in the right topics, but meeting people where they are in the moment, um, with with well-designed, well integrated um, solutions that shouldn't be a surprise to us, I think, but it's really encouraging to start to see to see that data.
But I think we we founded Jack uh four years ago which was very much a sort of social um mission a real purposeuh driven organization and it was to make an impact.
It was to make an impact in the world and and make an impact to to to individuals.
There's one particular uh user that will I'll always reference, but there are countless that we hear almost on a monthly basis that we did uh we did almost an on-site activation in a in a large uh national bank.
Uh and a user went into the bank and actually saw some Jack content that John Jack content uh happened to be uh Alistister Campbell talking about his uh experience with depression and actually almost moving into sort of suicidal thoughts behind that.
And that resonated with that user that that or that that um customer that had been going through something and just didn't understand it.
Um to the point that they then uh sought uh intervention, realized they were bordering on sort of suicidal thoughts.
Um had treatment for depression um and then took it up upon themselves to to both contact us and that bank.
just to say that that intervention that one moment walking into a bank that might have been to cash a check or to do a transaction completely changed that path of that user's life.
So yeah, amazing earlier intervention really does make a difference.
Um Rian and I'm going to come to you next.
How is BER innovating to enable earlier and faster access to mental health care through our products and pathways?
Yeah, it's great great to to talk about the pathways and products that we have here at Ber.
So we have the the business mental health advantage.
So Ber's mental health advantage removes common barriers to care by offering the most comprehensive mental health cover in the market including support for recurring conditions with no time limits.
So this means employees can access help quickly often without needing a GP referral with ongoing support so that they can receive access digital therapies access to a large network of mental health specialists.
We've also got as part of booper's connected care pathway um the members first um which is uh it's a recently designed product so new members first treatment options for mental health talking therapies.
It helps employees deal with various range of of mental health challenges from anxiety, depression, stress, burnout and with members first the costs are waved meaning there's no excess or co-ayments and no impact on that employee outpatient allowance.
So they get fast access to the mental health specialists and that care that they need and it's made really easy and hasslefree with booking via the ber app.
So they can manage their bookings with the app.
Now member first is included as standard for all our new and renewing theme customers.
Um for corporate clients on our ber evolve master trust.
This is a core part of the product.
To access these benefits customers must have mental health cover within their policy.
And we've got bluer and access to digital GP and well-being resources.
So the the ber app I mentioned before gives employees quick and easy access to the care that they need from GP appointments, mental health support from a ber clinician.
Um, within the app, we've got lots of digital well-being resources, some some really great uh trusted content um that can can really help people to understand what they're feeling and perhaps as we were talking here and Dan was saying that awareness piece that people might then go on to access further support.
And then we've got bluer well-being which includes some great well-being tools such as meditation and mindfulness which could be so valuable if you just want to, you know, you're having a really busy day, you want to clear your head or you just want to carve a bit of time out for yourself during a busy day.
Some fantastic resources there.
Great.
[clears throat] So, uh, two different access points, digital and talking to people or self-s serving.
But regardless of how someone wants to engage, we've got we've got a number of options which is good and and good new I I really like the um um members first.
Sorry, I was trying to get that in my head.
I can't say wrong.
Members first is great.
Um right, Sher, I'm going to come to you.
So uh what's the cost of doing nothing?
Uh not just for individuals but for organizations over the next few years.
So I think if you're doing nothing, the cost the money is already ticking and the cost is already ticking.
you know, you're not standing still.
You're increasing the risk of burnout, of staff, of talent loss, and of long-term work pressures.
And this is only, it's not a niche issue.
You know, as I say, one in five at the moment that we know about, and it's on the increase with increased life expectancy and people having um children later in life.
So again, it's it's it's going.
Um so we need to do something about it.
and and it actually costs age UK share that it actually costs5.3 billion pounds every year to organizations um to do nothing.
So actually the cost is there uh financially as well.
So personally the cost um and the risk of doing nothing for employees is that um in terms of mental health it increases um the risk of burnout as I say of stress and of anxiety and depression and eventually people leave organizations as I say because of the unable to continue to juggle everything.
And there was somebody I met at a conference a few weeks ago who it was a really emotional moment because she just came up to me and she'd heard what I do at Sage Generation Support and she said that was me.
I had to quit everything.
I had to leave altogether.
I just couldn't carry on and she'd looked after her dad who'd had Parkinson's um at the end of his life and she said that she'd literally finished work all together to support him and now she'd just come back into the workplace again.
So she because she'd not had that support and she sort of it was real emotional thing for me of actually it's doing something it's making a difference and I think the sort of organizational risk of doing nothing is that you're risking losing people you're miss risking your talent pipeline um all those kind of things you're risking your retention as I say your productivity everything goes down if people aren't supported properly so doing nothing is actually costing your workforce their mental health and it's costing your bottom line as well doing nothing not an option either for your business but especially for your people.
Absolutely.
It's all about the people.
So Dan, from the data and engagement you're seeing on Jack, what are people most actively seeking support for right now?
Yeah, I think before I answer this and it's important particular for those that are now accessing Jack just to understand that uh the data that that we hold is completely aggregated and anonymized.
So those users that are coming onto the platform um we immediately anonymize that.
So we don't know who is on the platform at what time and what profile.
I think that's just an important point to to caveat.
Um but we are we see some consistent trends uh throughout the year and I don't think these will be a surprise to to to lots of people but burnout, stress, sleep and addiction.
So they're showing up persistently across different organizations, cohorts, large organizations, uh small organizations.
What's more interesting is some of the emerging topics that are coming through.
So employees are increasingly engaging in topics that may have been considered taboo a few three four five years ago.
So these are addiction in various different forms that could be from tech addiction could be from porn addiction.
It could be from various different addictions.
Um we're seeing sexual health, we're seeing eating disorders.
Again if you go back sort of four, five, six years ago, they could be seen as taboo topics.
So these are real issues that people are carrying into the workplace that might be a difficult conversation with a manager, might be a difficult conversation picking up the phone to a counselor, an EAP, uh um or a therapist at that point.
So providing Jack as a really safe space that that's that has complete privacy, but being able to surface those early conversations is is super important for us to be able to continue doing.
Last month particularly again we saw um an emerging trend of ADHD.
It's a neurodeiversity topic.
Um and particularly trying to break that down.
It's understanding it from yourself managing it at work and navigating diagnostic uh as as an adult alongside burnout.
And there was another interesting uh um topic of alipcia that people were starting to uh uh to engage in.
So that just shows I think the breadth across the platform that people have accessibility to.
But I think the ADHD signal is really worth context of this particular story.
So if you look at many sandwich carers, you're sandwiched in between.
It could be children that have just recently been diagnosed or actually it could be yourself that's had a a later in year um diagnosis.
So again providing that support structure and information and pathways I think is increasingly um yeah so really interesting.
We like to uh position ourselves almost the sort of uh front view window in a in a or mirror in a car.
So we have real data, real life uh uh data rather than looking backwards in previous months.
Um and I think for organizations and ber members, I think that's critical and this data is available to uh to to ber members.
So we can start to spot trends in organizations whether that be due to political landscape, economical environment or actually is there something significant going on in your organization that we're then able to start to spot trends and support your well-being strategy that could be a big restructure within a business or it could be a particular change within a business.
Um but it's really important data that we're able to provide people in real time that can support business and organizational decisions.
Yeah, great.
such a range of different things, isn't it, as well?
And um important not to assume what somebody might be challenged with.
Again, opening up that conversation.
Interesting.
Although the data is anonymized, but those trends helping businesses manage change, for example, is a great feedback what might be showing up on a few different levels.
So, we try and break it into sort of three different levels.
So, there's there's a cultural piece that we can support.
there is an organizational piece and there's a behavioral health um piece that we're able to start to be able to create data that as you said is meaningful to an organization.
Great.
Thank you very much Dan.
So Sher, last set question before we come to the ones from the audience.
So uh let's finish with one final takeaway.
If employers could take just one action in the next 12 months to better support the mental health of their sandwich generation, what should it be?
So I actually asked this question.
and I've got um an advisory group with party of care consultant with nurse from um around different areas and for lots of people on the sandwich generation and I asked this question and the big thing that came back was about manager training.
It was about making sure that you know it was twothirds of managers um twothirds of people sorry um over twothirds that saying that understanding having an understanding line manager would make such a difference and that really came through from all the people in the sandwich generation the one thing because then you bring in your psychological safety and everything else we've talked about today.
So that was the one takeaway from me is train your managers to support people in the sandwich.
Any builds from you two?
Well, I think the the the the manager one is is a really interesting one for me because I think what we often see with supporting clients is managers often translate into a managerial role with actually without any formal training that go into it and then the expectation of being able to support populations is almost lumbered uh with those managers.
So I just think that that content awareness but building an infrastructure that allows managers to grow and inter leaders uh I think is really significant to allow that type of change.
Great.
Thank you R.
completely agree with the comments here.
I think the the awareness is getting there and I mentioned that before.
We've seen that over the last few years of that increase in mental health and the workplace awareness but just bridging that gap to actually the the the right support.
Um so the manager training um equipping our managers with with further awareness in those tools that they can support staff and then having platforms like Jack which actually can boost an individual's awareness as well and perhaps give them the confidence if they see something content that they can really relate to.
That's going to give them then hopefully that that that motivation to go okay gosh I I've read this this really relates to me I'm going to take the next step.
So yeah completely agree with the comments here.
I think there's often an expectation, isn't there, for managers that that you've always got the answers.
I know probably in in many of our careers as you start to sort of move through if it isn't a management positions that there's an expectation from your team, your employees that you should but but that's now impossible across the breadth of different topics.
So again, I think yeah, an organization has a responsibility to be able to equip and support with the different resources to be able to let that manager to really blossom and be a really great leader uh to to teams.
just don't I don't know what you mean actually.
I mean when I know everything [laughter] it's fine to say you don't know, isn't it?
And then come back.
I mean that's just you can't know everything.
So anyway, you heard it here first.
Uh equip your leaders to uh to lead their people would be a pretty good start.
Great.
Okay, so before we get to a couple more questions, our final poll, I know you've been waiting with baited breath.
So does your organization currently offer any targeted mental health support for employees in the sandwich generation?
Yes or no?
Okay, we've had a couple of questions come in uh from the audience.
So, Rian, I'm end Audience Q&A going to start with you.
Um, how are we expecting mental health challenges to evolve over the next 5 to 10 years and are they likely to continue to rise?
I think given the themes we've talked about today, yes, I think with the pace of change in that the rapid advancements with the AI and tech um and the current climate we've talked about today that that stress is going to be there.
Um, I think we've talked very much so about the strategies that we can use to support our staff.
Um, and that that coming back to the psychological safety and what we were just talking about as well, you know, really supporting our managers because there's always going to be stress in life and actually to support our staff being able to have that psychological safety and space for them to talk.
But it's okay for managers to say, "I don't know." It's important that they listen and they validate that experience.
I think that's such a key point here.
Great.
I think just to build on that and and um not to be sort of too negative about the data that that's rising, but I think it's important to flag um there's lots of conversations that we're having in different communities or research groups that there is an epidemic that that that could be upon us with the rise in in mental health um severities and and volume.
Um and if you continue to look at this sort of compounding trend plus everything we've spoke about today with sort of environment geopolitical etc it doesn't look like it's going to get any better anytime soon.
Um so we have this sort of systematic uh responsibility um the likes of of ber and providers supporting to be able to support organizations to be able to equip themselves and equip employees uh and and users um to be able to try and tackle that proactively.
And I think without a proactive uh systematic uh um strategy um I think some of the trends that really worrying uh uh to be honest for organizations um and for us as as sort of uh humans um coming coming through that.
So I think it's great that that the conversation is more open and we're able to be able to talk about it more.
Um that's got to continue.
Uh we can't stop stop uh that sort of continuation.
Um but certainly the sort of rise of severity and and potentially the sort of supply and demand uh between rising cases, rising in in those with suffering with mental health and perhaps not that rise of clinicians across the pool to be able to support that.
So I think the system has got to be able to make some significant preventative uh designs to be able to support this.
Yeah.
Great.
No, I agree.
And also there's not a great deal of of empathy in the world these days, is there?
If you look at sort of global leaders, we won't have a discussion about that because we'll be here all day, but for lead for for leaders in our business, being empathetic with their people and and leading them in the right way and creating those environments so important as a a start point and people don't just leave their mental health at the door, do they when they come in.
So great.
Okay.
So, um Sher, we've touched on this a little bit, but how can employers and managers provide sympathetic support without um overstepping into someone's personal life?
This comes up a lot actually and I think it's really important that ultimately somebody may not want to share at all uh for so many different reasons I think that we've talked about today.
So, I think it's very much creating that environment and if somebody wants to share that's absolutely fine and if not then it's about respecting that as well.
But I think sometimes if by not sharing things tend to turn up in different ways for example you know performance that kind of thing.
So so sometimes it comes up out from that kind of conversation instead.
So I think but it's very much ultimately about you've got to respect you know people's privacy and yes you bring your whole self to work but actually you know if people aren't ready to talk about that then that's absolutely fine.
So it's but it's providing the tools and materials so that when people are ready to talk about it or do need that access to that support they know what they're doing they know it's there and they know where to go.
Great.
Thank you very much and thank you to all of you.
That's the end of our questions um for today and what a great discussion.
I think the key takeouts for me, leadership plays such a a key role in creating the environment, making it safe for people to have open conversations, then being flexible with the employees, showing some empathy, but also then having those things like Jack and other uh solutions that sit behind that give people access to uh the support that they need and want at the earliest possible stage.
So important.
Uh we've had a great discussion today about mental health and the role employers and healthcare partners can play to better support their employees.
Thank you to all of our speakers for sharing your insights.
We also touched on preventative health.
So, just a final reminder that our healthy cities program returns in June.
A great way to get your teams out there and moving.
Uh if you'd like uh your people to take part in the 30-day challenge, speak to your account manager and they can uh get it lined up for you.
And as always, don't forget to keep an eye out for our follow-up email with valuable resources um there for you to learn more.
We'll be back with Health Horizons in quarter 3 focusing on inclusive health.
Stay tuned for more details and thank you for joining us today.
We look forward to seeing you in October.
The current landscape & why personalised healthcare matters
Good morning everyone and welcome to our first health horizon session of the year and for the first time coming to you
live from our new accelerate space at Bupa ace in Manchester.
It's great to have you with us today.
We'll be discussing the growing shift towards personalized healthcare and what it means for organizations looking to
better support their people through proactive preventative approaches.
To set the scene, let's highlight why
personalized healthcare is becoming such an important topic for employers and employees.
36% of UK adults say standard GP prescribed medicines often fail to meet
the need their health care needs.
58% of people believe that access to both standard and personalized medicine is
important and for every one pound invested in prevention employees see an average productivity return of4.
These
statistics highlight a growing opportunity for organizations to harness the benefits of personalized health care
and strengthen the overall well-being of their workforce.
It is no longer enough for healthcare providers to just treat
illness.
We need to work together with employers to predict, personalize, and prevent illness.
And that's why today
we're really proud to be announcing that we are the first major private medical insurer in the UK to offer fully
integrated genomicsled personalized and preventative health care as part of our standard cover.
This is how we plan to
redefine healthcare by giving all of our customers access to genomics to help them better predict their health risks
and proactively manage these with our new prevention pathways.
We'll be hearing from Dan on the details a bit
later on.
We've got our resident personalized health experts with us today.
And I'm delighted to be joined by
Dr.
Rebecca Rora, clinical innovations and genomics director at BER.
Uh Dr.
Rebecca leads Booper's clinical innovation strategy and has played a key role in developing our My Genomic Health
product.
Welcome Rebecca.
Uh we've got Dan Sullivan, product and proposition director at BER.
Dan is responsible for
defining our UK insurance product and proposition strategy.
Morning Dan.
You and Dr.
to Ravi Luca who is one of our
medical directors at ber.
Part of Ravi's role is being responsible for providing clinical oversight and support to the
development and delivery of clinical pathways within ber.
Morning Ravi.
Right, as always, please send us your
questions throughout the session.
We'll answer as many as we can later on in the Q&A.
And of course, we've got those
lovely polls that you all love so much.
So, look out for those along the way.
Right, lots to get through.
Let's get
started.
I'm going to come to you first, Robbie.
So um health care systems both public and private seem to be facing
increasing pressure.
Can you explain what is driving that?
Yeah absolutely.
So um both public and
private healthare systems are facing unprecedented pressures um due to a number of different convergent forces.
So first of all we have an aging population.
So we're living longer which is great but unfortunately we're spending more of that time in ill ill
health with long-term conditions things like metabolic conditions like type 2 diabetes.
adding in um pressures after
the pandemic and um rising drug and treatment costs um and we have a system
that's increasingly focused on treating illness late rather than preventing it earlier.
In fact, the most expensive
care care occurs when disease is advanced uh complex and avoidable.
Think
late cancers versus early stage cancers.
And health systems still spend the majority of resources at the end of that
pathway rather than upstream.
But these pressures also create a huge opportunity.
Um, prevention and
personalized medicine allow us to identify risks earlier, target intervention to those who benefit most
and keep people healthier for longer, which is our purpose here at BER.
Um, that's better for patients, better for
productivity and society, and ultimately ultimately the main sustainable way we can address these pressures.
Sounds like a bit of a no-brainer to me.
Really?
Absolutely.
I would say that given we're launching any product today.
[laughter] Okay, Dan,
coming to you.
So preventive health has been talked about for decades as a solution.
Why hasn't it why hasn't it
delivered until now and what's made it difficult to include these types of benefits in private health insurance
policies.
I think that's a great question.
I think before we do a bit of a reveal of what makes up um our new preventative
benefits just want to talk a little bit about some of those challenges that you put out in your question there Richard.
So more broadly, you know, I think preventive health has been thought of as a silver bullet for some of the challenges that that Ravi shared with
us.
But when you look at some of the preventative health strategies we talk about, particularly in some of our workplace, but more broadly for us, they
tend to have been quite generic.
So we've asked people to think about exercising better or having a good diet
and nutrition or avoiding certain risk factors like smoking, you know, or alcohol.
But what is really challenged
when you think about both first maybe for a consumer or an end user of healthcare is it hasn't felt very
personalized or tailored to them like what are their health risks what are their health goals and also how can they
see some progress you know about doing some of those right things when you turn them to an employer you know we
recognize that employers under a lot of pressure in terms of cost in their workplace scheme.
So it's been quite
difficult for employers to be able to point to the return on investment from investing in preventative health.
It's a
bit easier to you know understand why you might want to fix something but making an investment before something
you know has become a health event it's quite tricky and quite challenging unless you can see a a clear outcome from that and then when you think about
as a health insurer as a health insurer if we put you know and as we have but you'll see our thinking is a bit
different but if you put preventative health benefits whether that's screening or preventative treatment into a product
it's quite hard to make sure that the right customers will use those pathways and those services and will benefit or
you won't get the wrong customers using that potentially repeatedly which is then driving up repeated you know
ineffective cost in terms of the product.
So we think you know that's why
that prevented health has taken this long and it's actually taken us quite a lot of work to get to this point today
and that's why health insurance is typically then focused on fixing acute short-term conditions and hasn't moved
in a really significant way into this step before.
So it's really moving from sort of more generic to much more
specific.
The science catching up in a way.
Yeah.
Okay.
Um so Rebecca, what's different now in terms of technology and
data that makes preventive and personalized healthcare uh genuinely viable for the first time?
Yeah, I mean techn technology is like a really key enabler for all of this and it's only really at this point that it's
enabled this proper shift from reactive to proactive healthcare.
I think there's a couple of factors there.
The first is
the genomic technology that we've got.
You know, the technology that takes a DNA sample and it sequences it and then
it puts it into a piece of code.
That the price of that has gone down significantly um over the last 5 years
and we're still seeing you know that that technology get cheaper and cheaper.
It's also faster.
I think the second
thing is around the data that we get from those insights um and you know the
evidence level that we have around translating what genomic factors you have to the risk of that causing a
disease and then what interventions are going to work afterwards.
So it's that kind of genomic technology coming
together with the scientific literature.
Um and then of course the use of data integration technology like AI to be
able to bring that all together to make those insights really rich.
That's important for us as clinicians because it allows us to be really confident that
the recommendations we're made may we're making are you know evidence-based and they're safe but also allows us
importantly to be able to translate that into a really easy to way to understand for customers as well um and for us to
be able to consult in a different way.
Great.
And it's important to say isn't it this is risk factors rather than you have got something.
Totally.
Yeah.
Okay.
Cool.
Dan, so coming to you, uh, what gives ber a unique advantage in delivering
personalized preventative health compared to other UK insurers?
Yeah, I think I think it builds on what
Rebecca talked about there, but I think about there's three key enablers and that's why now is the moment that we can
go and start to launch.
And actually we talk about you know the first step for us is personalized health we think is
going to be a big macro trend in healthcare and it's something that we and b are investing a lot in and we think it was going to define the next 5
to 10 years of how we think about our services within that I think there are three key bits.
So first up is
healthcare data.
So I touched on earlier unless you can spot the right customers who will benefit from investment in
preventative healthcare you'll really struggle to make the economics.
So if you think about the data we have from
our genomics pilot of 12,000 people, we've understood better in terms of how genomics and health and how customers
respond to that.
Next up is we do a lot of preventative health already things like health assessments.
So we
understand different risk factors that we see coming through and we're also in the fortunate position of having one of
the UK's largest healthcare databases being such a large health insurer in terms of claims data.
So all of those
things come together give us a really unique view in terms of how these health risk and these factors interact.
Next up
then is connected care.
So personalized and preventative health programs are a
bit more complex often but to simplify those and make sure that customers get a really good experience we have the
ability to manage that end to end.
So being able to deliver the genomic services inhouse, the primary care
appointments with GPS, geneticists, some of our specialist oncologists for example, all of those services can be
delivered end to end through a booper journey.
So customers aren't left navigating because some of the broader
healthare system, you know, might not know how to interact with that.
So really important that we can do that through the connected care pathways.
And
then the third bit is digital guiding customers through those journeys, tracking the outcomes, nudging them to
engage with the next step in that journey because of my ber because of the millions of customers you now have access to that we can guide them through
that well in a really intuitive and easy to follow way.
Great.
So really moving beyond being a
funer and and powering you know provision knitting it all together so we can give the full end to end experience.
Exactly.
This is really integrated
healthcare you know I think at probably one of our best examples to date.
Great.
Okay.
Thank you very much.
Well,
well, that's a great start.
Thank you very much.
Okay, it's been great to hear how the landscape is evolving and the
insight about technology finally enables us to deliver preventive and personalized health.
Um, plenty to think
about.
We're going to move on in a second, but before we do move on, I know you've all been waiting.
Here's the poll.
Uh, right.
Does your organization
currently offer any personalized health benefits to employees?
Yes or no?
And we'll come back with the answers later.
Bringing it to life – Bupa’s solutions, new innovations & future outlook
Okay.
Uh, so let's move on to the next part of today's session.
We'll look into the latest innovations and what the
future looks like for preventative and personalized health.
And we'll also explore how BER can support your
employees with preventative care.
And we'll be asking Dan to recap on the exciting news that we announced today
that we will make personalized and preventative care available to all our insurance customers.
Right, let's get
going.
Coming to you Ravi, first um could you talk us through the personalized health plans a bit more?
what uh do they involve and how will they support our customers with preventative health?
Yeah, sure.
And as we've discussed already, these are bringing these ideas of what we we think the trends are, what we know the trends are into reality.
So,
our personalized health plans are built on that kind of foundation principle that everyone's health journey is different.
What works for one person
doesn't necessarily work for another person.
So, these plans are about um designing it specific to people so it's
relevant to them.
So they sit in the my booper app going back to that that integration point that we just discussed
and offer clear easy to follow advice tips and tools tailored what someone wants to work on.
Members start with a
short questionnaire which gives them their own lifestyle insights um on things they want to focus on whether
that's fitness uh sleep diet or mental well-being.
From a preventive health point of view the focus is on those
early practical uh action and insights.
Each plan runs over three weeks.
Uh has
written uh video and audio content from guides and recipes to meditations and
fitness sessions.
And it's all introduced by one of our clinical leads.
So it's really exciting.
This is just
the beginning.
Uh as we expand the range of plans, we're building something that helps people take those next positive
steps in prevention again and again.
Great.
Okay.
Thank you very much.
So I'm going to come to you Rebecca to talk
about businesses.
So could you talk us through the benefits that personalized health brings to businesses and why it
should now be a priority for organizations across the UK?
I mean I always find it amazing that 80%
of our healthcare outcomes are affected by things that are completely outside traditional healthcare.
So genomics,
lifestyle, behavior, the environment that we live in and that we're not operating in a healthare system that
really accommodates that.
So that's what's so exciting about about this move.
Um why it's important for
employers is because um you know that cookie cutter approach um you know
one-sizefits-all just you know it doesn't it doesn't need to operate like that anymore.
Um and actually they're
able to be able to you know understand the risk within their population and then to be able to tailor plans and
benefits based on that risk going forward.
We know from your stat earlier that that leads to improved
productivity.
It also leads to improved retention.
We know that threearters of employees would rather stay with an
employer uh who offered some personalized health benefits.
So it really does make sense from the from the
employer and the employee side.
I think really importantly for employees, we also know that if you're receiving
personalized insights, you're more likely to stick with them.
You're more likely to actually um you know make that
part of your lifestyle.
Um and and so it it offers wider benefits as well.
Great.
Thank you.
So we've heard about the employee Ravi employer Dan.
Today we're announcing uh the launch of our
new prevention pathways.
Can you explain what what this means for customers?
I think we've teased enough now in terms
of what they are.
So now we're going to get into the uh into the grand reveal.
So you know we are really excited.
We
think this is probably one of the biggest developments in in private medical insurance um in many years.
So
um building on all that you've heard from from Dr.
Ravi and Rebecca there.
Um, our new preventative pathways will
initially cover four areas.
So, first up for that is uh we'll offer a breast
cancer prevention pathway.
We'll offer type 2 diabetes prevention pathway, a cardiovascular disease pathway and also
our metich medication check sorry product that helps spot for customers if they're taking regular medication
whether those medications will be suitable and work for them or maybe they should take an alternative.
Um so this
is a big shift.
Um customers won't need to be symptomatic to benefit from these
and they will take um digital assessments in our my booper app to understand using clinical um risk
assessment tools as well as genomic testing their risk of disease for these um and then we'll proceed through a
preventative pathway.
So if I zoom in on the uh breast cancer prevention pathway,
customers answer a series of questions.
um if they come up at an elevated risk they will be offered then genetic
testing including high-risisk gene uh panel which will test the things like the bracka genes.
If customers then have
a risk identified through that even when not asymptomatic they will then be offered preventative treatment which
clinically medication like temoxifen or um preventative surgery like a masectomy.
So really powerful statement
of intent and I think we're really proud of how we're leading the market in our cardiovascular disease um and also type
two diabetes pathways.
Very similar model digital assessment looking for risk factors.
Um we will then offer
customers our um capabilities around nutrition but also our weight management
products with funding available there to access GLP medication where clinically suitable for them as well.
So it's both
medication really um I think thoughtful risk assessment using digital tools and clinical including genetic testing but
then treatment as well and these will be offered as standard uh for all of our theme and consumer so we back that this
is going to have a really impactful impact so we're putting a standard into those products and for our corporate customers they'll be able to choose this
as an optional benefit so currently the medication check product is available for customers to opt into uh for
corporate customers they can choose to switch all of these pathways on uh from September.
And we've likened it a little
bit like your house insurer offering to pay for your smoke detectors, right?
You know, this is really invest this is
really rethinking right what insurance is there for rather than funding when an adverse event happens like a diagnosis
of disease.
This is actually funding and managing preventative health care before the event.
So, you know, we think um
we're just getting started, but we think this is going to be a really important step into a new era of how private
health care works um in the UK.
Great.
So employers can really empower
their people to manage their health proactively um for the first time with some interventions off the market
and I think every you know employees will then have a really good understanding of the health risks that they face and they can make some very
specific choices whether that's diet whether that's exercise whether that's thinking about you know going into um
having preventative treatment but very specific to their own individual risks.
Great thanks Dan.
Okay.
So, Ravi, from a
clinical perspective, what are the most important elements in designing a seamless and safe experience for employees using personalized and
preventative initiatives?
Yeah, sure.
So, there's a number of um clinical elements that we've already touched on but are really important in
in the design of these types of initiatives.
So, firstly, it's about clarity.
People need to understand what
the initiative is for, what it's telling them, and what, if anything, they need to do next.
So if we think about our
type 2 diabetes prevention pathway, it's about identifying those risks early, explaining clearly what those mean
without any jargon and so it's clear to each individual and what they then need to do next if anything at all.
Um
secondly, it's about safety and proper medical oversight.
So all these types of initiatives have to be um
evidence-based, clinically overseen, and have a clear route to follow up again if there is anything that's identified.
Thirdly, and this is really important, it's trust.
Employees must be confident that their data is confidential and used
responsibly.
Especially if we think about things like genetic data, that's obviously really important and paramount to any uh type of initiative.
Um, and
underpinning all of those for me is is integration, which Rebecca touched on already.
If we think about how
somebody's health exists and also their life, we can really build something that's personalized for them that's going to really help them engage in and
not exist in a silo or in isolation.
Right.
Thank you.
I love that clarity point in particular is you know people
[clears throat] worry don't they about their health a lot and actually giving you know real clarity around what the risks are and what you can do about it
is super important and Rebecca coming to you so looking ahead at future advancements what should
we be excited about in the world of personalized healthcare I mean I think we should be excited about everything I mean this is this is going to become
the new norm right so um I think there's there's three things I'm super excited about so I think anything as a clinician
that will allow me to be able to predict risk better is great, right?
So, you
know, if I can predict risk of developing cardiovascular disease or diabetes or breast cancer in my patient,
uh then that totally changes the kind of recommendations I can make to them.
It totally changes the consultation type
that I can have.
We can make some shared decisions around what is best for that particular customer um given their, you
know, lifestyle and and the things that makes us all unique.
For medications, I'm super excited about it.
So, you
know, Dan mentioned that medication check is is going to be one of the, you know, the elements introduced for
consumers andmemes.
That means that actually we're able to make recommendations around what
medicines work for people or don't work for people based on their genetics.
Um,
that covers super common medications like anti-depressants, antibiotics, but
also over-the-counter painkillers and some of those really specialist hospital medicines.
And actually that allows me
to be able to prescribe the right dose to the right patient first time.
Um and
that that's a total gamecher.
So we see in self-insured populations in the US that actually taking a very bespoke
approach to prescribing can reduce impatient and emergency admissions by 39%.
Because it, you know, allows you to to not try multiple drugs.
You can get straight onto the right drug.
You have
fewer adverse effects because you know what's going to work for you.
So actually it has really long-term financial benefits as well.
And I think
the the third is around the clinical pathways.
We're all used to having clinical pathways that everybody goes
through.
Actually the ability to be able to bespoke that to our own risk and the way that we might like to receive and
you know the best way that we're going to respond to care is super exciting and it's something that we've we've wanted to do for a long time in healthcare but
we've just not been able to get there.
Great.
That 39% is huge, isn't it?
So taking out the trial and error.
Yeah.
That's massive.
Okay.
So, uh, Ravi, what's the biggest misconception you see about gene testing and how would
you explain the reality?
Yeah, and you already touched on this already, Richard.
For me, the biggest misconception that I see about genetic
testing is that it always gives you a clear answer about what will happen to your health.
Uh, and that's just not the
case.
Um, for many tests in particular, and I'll touch on a few later, what it does tell you about is about risk, uh,
not certainty.
uh and that fits on fits in with um a variety of other information like your lifestyle
information, wearable data can feed into that.
The environment, family history and other things.
So you kind of kind of
put got to put the picture all together.
Um there are some important exceptions and we've already talked about some of
these exciting ones already or important that we identify them and deal with them appropriately.
So some tests do look for
specific genes such as you might have heard of the bracka genes in in uh breast cancer which really does increase
your your your risk.
Um and in those cases the results generally shape you know how we how we deal with patients
from a risk reduction perspective.
Um and that needs careful explanation again around that clarity point about what
that means and what somebody needs to do to address that.
Uh and again that's part of our breast cancer prevention
pathway.
Um it's also used to help with medications as Rebecca just said through our medication check.
um product.
And
again, it's something I'm really excited about because for the first time ever in in my career, you can really personalize
the the medication that we prescribe that we might nag someone to take.
We know that this is going to a work
effectively, but also have a a lower risk of causing adverse effects or or
side effects.
And that's for really common medication.
So, so we're really building into that personalized picture,
uh which is super exciting.
Um and so so ultimately it sits on a spectrum from
those higher risk rarer diseases to medication guidance to also those kind of broader risk insights thinking more
about our cardiovascular disease and type two diabetes prevention pathways that helps guide the prevention that you
can do kind of downstream.
So it's not about labeling people it's about giving that clear information earlier so it can
inform uh better decisions over time.
Great.
Thank you.
Um, so just we we've
got a couple more set questions and then we're going to Q&A.
So get your questions in.
There are a couple uh quite a few actually coming up.
Dan,
you're definitely going to be in the chair and myself just just to let you know.
Before we get to that though, uh I'm going to come to you on this one.
There's often a perception that more preventative benefits could increase the overall cost of private healthcare.
From
your perspective, will these uh benefits help address the challenges of rising demand and cost pressures or add to
them?
Yeah.
Yeah, we're very mindful of the the right to demand for those who came to our accelerate event in January.
You
know, that's a key focus for us this year in terms of being able to sort of drive cost efficiencies and help
employers manage the sustainability of their healthare schemes going forward.
If you look at the drivers of some of
the inflation we've seen coming through, it's a lot about incidents.
So, more people claiming on their private
healthcare because they need more support, but also severity, right?
you know in terms of us seeing more complex
latest stage and I think Ravi talked about this latestage cancer claims coming through.
So if we could intervene
and spot some of those cases earlier this will then have a positive impact.
Um I also talked about the four pathways
we've been very thoughtful about which pathways we start with where we have really robust claims and clinical data
that suggest this is going to have a positive impact on the sustainability of that scheme.
So our ambition is is this
is about moving money to focus on doing the right things with the right impact rather than having a significantly cost
inflation view, you know, in terms of these healthcare schemes.
And what we expect to see is that for employers, you
know, where they embrace preventative health, they should start to see then their workforce becomes healthier.
They
start to see some of those instances of verity movement move in the right direction.
But also one thing that employers have often struggled with and
I think we see it here at BER is engagement with health care has been tough.
But when you're equipping
customers with a personalized view and you've got really convenient, easy to access well-being and intervention
services, engagement with health, we think will also increase as well.
And just to finish, you know, one of the big
use cases, you know, we talked about Ravi and Rebecca about medication check.
You know, one of the biggest drivers of
uh health inflation has been mental health.
And actually for medication check, one of the very common outcomes
we see for medication is customers aren't respond that customer might not be responding to anti-depressant
medication.
That means that customer then mental health isn't improving.
They then become chronically unwell that puts
then higher cost psychiatry services demand on that healthare scheme and then all of the absence.
So this would have a
really powerful way of actually intervening is what's a very common driver of healthare costs at the moment.
Great.
So it's kind of multi-layer benefits, isn't it?
hopefully control medical inflation for the employer who's looking to afford this for as many
people as possible, but actually for the employee or the consumer, you know, much more engaging and hopefully get better
quicker or get intervention faster and ultimately, you know, have a longer, healthier, happier life.
Exactly.
It's like I worked our uh [laughter] our purpose into that, isn't it?
Seamless
almost by mistake.
Right, Rebecca, coming to you.
So, can you share some of the clinical thinking behind our
ambition for preventative benefits and how it supports improved outcomes across the four pathways we're launching today?
There's a lot of really clever science in in these pathways uh and in this benefit, but fundamentally it comes down
to a pretty simple clinical uh principle which is if you can understand somebody's risk of developing disease,
you can intervene earlier.
And by intervening earlier, you can either avoid that condition from happening in
the first place or you can diagnose it earlier and therefore avoid cost and
adverse outcomes further down the the line.
So, you know, that that's what I
always keep top of mind as a clinician.
What I love about it is it allows us to
consult in a completely different way.
It allows us to have much more rounded conversations with customers about their
lifestyle, their underlying risk factors, their family history, what is important to them.
Um, and you know,
we've mentioned a lot about people um engaging in these pathways, but actually if people don't want to engage in those
pathways, that is a really helpful conversation for us to have with them as well.
Um, so you know, by by being able
to open up those conversations and by them having the information to feel that they're in the driving seat of their
health, that they can have autonomy over their own healthcare, we can have some really good shared decision-m around
what the best treatment for them is and how they like to receive it.
Great.
Thank you very much.
Right, set
questions done.
There's lots on here.
Uh, but another poll.
Another poll.
Okay.
Uh do you feel your organization understands the value of personalized health for employees?
Yes or no?
And uh
hopefully we'll have the uh outcomes later on.
Right.
I've got questions for all of you here.
So I'm going to come to
end Audience Q&A
you Dan first.
Um firstly, is there an additional cost to employers for
switching on the new pathways?
First question.
Yeah, there will be.
So there will be a risk based charge that applies.
So um
it'll depend on the type of scheme.
So for corporate they will make a choice about how that is applied in our theme
policies we're reviewing the premiums.
It's actually a very modest increase to premiums.
If you then look at the way um
these benefits are structured for medication check where the benefit is get as many of the employees or the
customers screened in terms of their medication outcomes.
Um there are no co-pays or um any excesses or benefit
limit impact for the individuals but it would feed into policies um for our preventative pathways.
A very small
co-pay of100 pounds applies to each access to that pathway.
Great.
Thank you very much.
Okay, Ravi,
I'm going to come to you now.
So, do you think we will end up in a world where every single person has a wearable and
without this, do you think we can really move to personalized health?
Good question.
I'm slightly biased.
I
have two wearables that I use.
Um I think look it's the um it's absolutely
the direction of travel because as I said it's part of that suite of information that tells us more about an
indivi individual.
There's that [clears throat] risk part of it but also what are you doing um may I say
objectively as well what are you doing on a on a consistent basis if it's related to activity sleep what I use it
to personally for and how I can improve it.
So absolutely it adds into that kind of um information that we can then use
as clinicians to really guide that that personalized um messaging for each individual but also that prevention
piece as well which is what's most important about that type of data coming in.
Wearables also have really important
things such as uh high-risisk things they might tell somebody if they go into at a regular heart rate and then
somebody can go to their GP and deal with that appropriately and we're going to see technology within wearables just
improve over the next few years let alone kind of decades or so.
So I think it is really really important stuff each
obviously to their own.
you might focus it more on a um optimization kind of point around what how you want to go,
you know, be better at cycling or running or something like that or it might be more focus around your kind of health if you've got a chronic disease.
So, it's, you know, they're really flexible and useful for all.
Yeah.
Great.
Thank you.
I know in our Sanas business in Spain, they the
wearables like work with the app and so on and and the GPS.
It's super smart.
Hopefully, we'll get there.
Okay, Dan, I'm going to come back to you.
So, um there are a few for you by the way.
[laughter] Sorry about that.
Extended session session with Dan.
Uh so uh you talked about the pricing impact.
Um can we use this data to inform our pricing?
Yeah.
No is the simple answer.
So so
we're subscription um subscription we sign up sorry to the AI code on genetic testing.
So you we think this should be
a very positive uh impact on customers and I think Rebecca talked about trust
being so important in terms of how our customers engage.
So by being signed up to the ABI code what that means is we
would never compel a customer to take a genetic test.
They are always optional and you can proceed into the prevention
pathways without taking a genetic test if that's your preference.
What the ABI code also means is that we can't use any
of the genetic uh data that we gather to either deny or change the price for
cover.
So it has absolutely no impact in terms of your insurance premium or your availability of insurance.
It's it's
purely about adding value and personalizing healthcare to you as an individual.
So it's just about empowering the
employee or the consumer to take action.
Yeah, we have really strict privacy safeguards.
So we want customers to feel
in control of their health data and really using it to drive what they want and that's a key key part really of
that.
Okay, great.
Thank you.
Uh Rebecca coming to you.
So what barriers are there to people wanting to use genomic
testing that you see from customers and how do booper plan to overcome these?
I think genomics is a bit like wearables.
You know the best wearable and the best genomics test is one that a
customer will use.
So um you know part of the rationale for having medication check and the those defined pathways is
that there are different genomic tests depending on what your particular personal concerns are.
Right?
So, if you
are on long-term medication and you are concerned whether or not that's working
for you, then medication check is great because it allows you to be able to
understand for your current medication, but also for any medication that you might happen happen to be on in the
future, how that interacts with your genetic profile, and you get some GP time to be able to discuss any concerns
or any prescribing guidance based on that.
Right?
If you've got particular concerns about cardiovascular disease,
diabetes, uh breast cancer, then actually that allows you to to be able
to to look into those um concerns in detail um through you know the the
digital algorithm and then any genetic testing and then obviously um any onward
pathways.
So what we don't want is people lying in bed at night thinking, you know, gosh, I'm really worried about
that breast cancer risk.
You know, a friend or my sister's just been diagnosed.
I'm really worried about it.
We don't want you to be worried about
it.
Come speak to us.
We can help to, you know, allay and to manage that risk.
Right?
So, I really think that um you know that there's there's a genomic test available
for everybody based on their particular concerns essentially.
Great.
Thank you very much.
Okay, Dan,
there's a request.
Can you recap on which conditions the new prevention pathways will cover and do you have any
plans to open these pathways to more conditions specifically mental health?
Yep, good question.
So to recap, so the
the four um prevention pathways we're talking today.
So uh breast cancer.
So any customer at risk or thinking they
might be at risk of breast cancer can take a digital assessment.
We will then look at for genes.
We will test for the
bracket genes as well as other high-risisk genes.
Um and then we will offer preventative treatment including
medication um and surgery.
So masectomies and ofctomy which I think I got right take I can't spell it but I
can say it now.
So um and that takes it all the way through to treatment and then risk mitigation.
Uh we also then
have a type two diabetes pathway that includes access to nutrition and also
our weight management service.
And then the cardiovascular disease pathway is similar.
So digital assessment access to
u in bluer we have exercise we have fitness and programs but that those customers in that pathway have also got
access uh to the weight management service from ber those three pathways will launch as standard to all theme and
consumer customers from the 1st of September.
They'll also available to corporates for their renewals starting
uh on the 1st of September and my booper will be at the center of how customers use and navigate those pathways.
The
fourth we talked about is medication check.
Medication check will be available to all customers from the 1st
of June inme and consumer and our corporate customers can already add that
uh to their products today.
Great.
Thank you.
And coming next?
Yep.
Coming next.
Yeah, I'm not going to do a grand reveal, but yeah, we have not
stopped here, right?
So, um we are thinking really carefully about where we go next.
Mental health is one of the
things we're looking at.
Um it's quite a broad spectrum.
I'm not a clinician, so I'll leave it to my clinician colleagues here.
That's quite a broad spectrum of
things but you know there are other cancers uh in particular that we're looking at.
So you know we think there
are a number of areas but we want to do is to make sure that we do this in a really sustainable way so our customers
can understand the benefits and then we start to expand those as we see that claims and that healthcare data coming
through.
Yeah, great.
Thank you very much.
Uh, got any builds comments?
I think for for me on the places where we started for type two diabetes, cardiovascular disease and breast cancer
in the first instance, what's really important about that, I started off by saying we're we're living longer, great, but in poor health and those are really
important conditions that are driving that.
Um, and what's great is this information isn't academic.
We know what
we can do to address it if somebody is found to be at higher risk.
Dan mentioned with regards to breast cancer, the very specific things that people can
do if they have these high-risisk genes, but also for cardiovascular disease and type two diabetes, there's there's
things that we can do or advise people to do with support from BER that will help um reduce their their risk.
And
then comes in that engagement piece, that personalization piece about how them it works best, whatever exercise
mode that is, um whatever diet it is that works for them, and it's supporting them through that journey that we all
frankly live with dayto-day.
Right.
Yeah.
Yeah.
I think is right in saying that the for diabetic customers when they then go into hospital setting they
are much more complex and expensive for us to treat.
So this has a a broader
impact just behind that particular disease as well.
Yeah.
Great.
That's a good case for it all
around I think.
Uh so Rebecca coming to you.
Uh can you talk to the results of the my genomic pilot um that BER ran?
um
were there any long-term benefits you can talk to and will there be any further information released?
Yeah, so the genomic health pilot for those of you who weren't aware was a was a global pilot of 12,000 participants uh
in the UK, Spain, um and and some other markets around the world as well.
Um and
that looked at whole genome sequencing for actionable conditions.
So we were only testing conditions that we knew we
could do something about.
That's really really important.
we are not in the business of telling people about genomic risk that we can't manage right um and
that that gave some insights that I think directly impacted you know the direction of travel that we've gone so
99% of those individuals had a uh genomic variation that impacted common
medication um so as I mentioned before um you know that that includes things
like common anti-depressants that I would prescribe you know in my in my job as a GP antibiotics painkillers, um
things like ibuprofen that you can get over the counter, but also things like chemotherapy agents that that you might
have in hospital.
Um so, you know, just given the the huge number of people that
were impacted by that, and we've had people who um you know, have been on long-term uh tummy protection
medication, but still symptomatic with it, have had camera tests and lots of other invasive testing, and actually,
it's just turned out that they've been on a medication that they just weren't responding to.
So, we've been able to switch their medication.
They've been
symptom free.
Uh Dan talked about the anti-depressant uh case example.
That's
really important because if I'm prescribing an anti-depressant and somebody comes back to me and they're not feeling any better at the moment, I
don't know whether I need to increase the dose of the current medication, whether actually something else is going on and they may need a bit more support.
Actually, with these kinds of insights, I can just make sure that they're put on the right anti-depressant first time and I'm even even able to dose adjust on it.
The other thing that was really telling was that uh about three quarters of individuals had a polygenic risk score.
That's where lots of genes come together to affect the risk of cardiovascular disease, breast cancer uh and um and
diabetes.
Um and that's directly resulted in the in the pathways that we see today because actually we were able
to understand how you communicate that risk to customers, how we intervene and
the long-term effects.
And you know in the case about breast cancer we've had individuals come through with
preventative mistctomies and frectomies as a direct result of of a bracka new bracka diagnosis and that's you know
proven that actually that that saves lives in the long term.
Super exciting.
Right.
Thank you very much.
Ravi got
another one on wearables.
You're becoming our wearable expert.
How reliable is wearable data for detecting
early signs of illness?
Yeah.
So, um I suppose it depends on specifically which
illness um that that someone might be referring to.
And as I said before, a lot of this technology is is developing.
Um so, one thing that wearables actually has been have been focusing on is actually mental health, which I'll
start, which is quite interesting.
Uh understanding if somebody's maybe displaying signs of anxiety um or or
stress different to their baseline.
That's why it's so useful because it knows your baseline from however long you've been wearing wearing it for for
that that that period.
Um so that's one example of where it might give a signal
a sign.
It's not necessarily diagnostic but it can support that conversation you have with your clinician.
Um the example
I gave before the condition is called atrial fibrillation or AF.
Essentially that means an irregular heartbeat and
that's really important because it can give you symptoms such as palpitations but it can increase your risk of having
a stroke.
Now they have been validated for um for for diagnosing those
conditions or at least again pointed to the signs that you then get an ECG and further test.
So for example the Apple Watch I'm wearing can do that if you
just put your finger on the dial and it can can measure that within uh 30 seconds.
So again, they're definitely
developing in in that space.
But but to really hit home the point, it's about giving more information to the
individual who can then take it to their clinician and say, "This is what I felt and this is some also some objective
measures as well that's coming up with my wearables that will help support each individual disease diagnosis and then
you can go through the kind of gold standard proper diagnosis.
" So it's about bringing all the data together as you said before really isn't
it?
All the different data sources.
Yeah.
Because personally I I love that if somebody has that more information including that objective information
then you can really go off that um and and build this picture of someone to then give that that definitive
diagnosis.
Great.
Thank you very much.
Okay Dan, uh is this just a UK initiative?
Will it be
extended to Ber Global for example?
Yeah, so our ber global customers will be able to benefit from preventative um
benefits and services already built into their product.
little bit different um but yeah there are we have got a lot of
ambitions to roll this out more broadly also our businesses in Spain and also
Australia are also investing and have got similar pathways that are under development as well so this is a big you
know Rebecca talked to around a global pilot for genomics that this is something that the ber group is doing
you know across the piece as well yeah it's about being appropriate to location isn't it exactly and different products have
different design right so the way that this works will be slightly different but sharing some of those common themes particularly around uh personalization
of health.
Yeah, great.
Thank you very much.
Look, thank you very much.
What a great discussion.
Um it's been really good to
learn all about genomics and that brings today's session to a close.
We've had a
great discussion uh about the latest innovations in personalized health and the growing importance of prevention.
With prevention in mind, a quick
reminder that our healthy cities program is back in June.
Great way to encourage your teams to get moving.
Uh if you want
to get your people involved in the 30-day challenge, please speak to your account manager and they'll be able to
uh to sort you out.
Look, I hopefully it's come across today.
We are passionate at BER about our opportunity
to play a big role in employees and consumers health by um really living our
purpose to help people live longer, healthier, happier lives.
We're uniquely um positioned um to be able to offer not
just the funding, but also the health care that goes around all that.
And we we believe it's our privilege to be able
to bring that to you.
So, I hope you've enjoyed the first uh launch of that and and much more to come.
So, uh that's it
for today.
Uh and health our health horizon session will be back in May focusing on mental health.
Stay tuned
for more details and thank you for joining us.
We look forward to seeing you very soon.
Explore insights from our archive
Find insights from previous events on a range of health topics.
-
Mental health
-
Inclusion
-
Women’s health
-
Men’s health
-
Cancer
-
Prevention
How leaders can build more resilient teams
Many organisations now recognise the importance of investing in workplace mental health. But there’s still a gap between how leaders view their team's mental health, and how employees experience it.
How neurodiversity impacts mental health
Explore how to provide tailored support for neurodiversity and strategies to embed resilience in your workplace.
Children in need of mental health support
We are facing a crisis in children’s mental health. We explore the possible reasons why children are likely to be struggling.
Supporting child mental health delivers dividends
Learn more about the challenges facing families and the business benefits of creating a culture for change and providing effective support.
How businesses can help
There is no one-size-fits-all solution, but the key is to encourage working parents to share their concerns before their children are in crisis.
How parenting can impact mental health
Deciding it’s time to start a family is a major life moment. But sometimes, feelings of elation and excitement can be interwoven with negative emotions. For example, anxiety, depression, and self-doubts.
Investing in mental health is a priority
Discover what makes an effective workplace programme in our article. We'll also give you the tools and resources to signpost to support emotional wellbeing across your teams.
Upskill managers to support mental health
We explore how to support employees’ mental health with core standards that aim to embed positive policies and good practice.
Financial uncertainty
Learn how businesses can support teams and the dividends this delivers in productivity and employee retention.
Reaping the neurodiversity dividend
Learn how changes to policy and practice can help to recruit neurodiverse talent and embed resilience.
Putting awareness into action
Learn how to give clear routes to diagnosis for neurodiversity and make sure line managers have the training and tools to build resilient teams. Explore how these strategies can deliver across-the-board benefits.
Psychological health and safety in the workplace
Creating a psychologically healthy and safe work environment means identifying and managing the work-related factors that may pose a risk to employees’ mental health.
Creating a healthy workplace culture
Discover what it takes to develop, and maintain, workplace wellbeing initiatives that are tailored to the needs of your teams.
Age diversity dividends
As the risk of health problems increases and evolves with age, we explore how providing the right healthcare support will enhance recruitment and retain talent.
Addressing disability in the workplace
Learn how to support the needs of team members with different disabilities by asking questions and encouraging open communication.
Creating a family-friendly workplace
We explore the core elements of an effective strategy and provide practical advice and tips on how to foster a family-friendly workplace for all.
Fertility is becoming a business issue
As many as one in seven couples has difficulty conceiving and while fertility treatment offers hope, it is often associated with depression and anxiety. Explore the issues and how to support employees on this path to parenthood.
Women’s health in the workplace
Women now make up 48% of the workforce, menopausal women are the fastest growing demographic in the workplace. Offering the right support will give organisations an edge in the competition for talent.
The silent crisis in men’s health
Many men struggle to open up about their health, which is why it's important that organisations provide access to the right support.
Supporting men with fertility issues
We explore the underlying causes of infertility, and the impact these issues can have on men’s mental health and sense of self, at home and in the workplace.
Tackling the crisis in men's mental health
Men are at much higher risk of poor mental health than women. Learn how to meet this challenge and discover how one firm in a male-dominated industry is making a difference.
Developing men’s mental health support that delivers
Poor mental health is a leading cause of absence, but men often delay seeking help. We explore why men might do this, and to provide tailored initiatives to support men’s health in the workplace.
Rapid advances in cancer care
Cancer care is changing. Innovations like genomics, immunology, robotics, and artificial intelligence (AI) are working together to make cancer treatment more personal and precise. We look at the incredible advances and explore how Bupa can help your business.
The right support can improve cancer outcomes
Support at work plays a big role in improving cancer care by helping with early diagnosis, mental health and flexible working. Empower managers, share wellbeing resources, and create a caring environment to help employees through treatment and recovery.
Genomics and AI are driving cancer prevention
Discover how joined-up wellbeing support and workplace initiatives to encourage healthy lifestyle choices could help your employees understand the risk of cancer and other serious health conditions
Supporting the health of your multigenerational workforce
Employees don’t all think, work or live the same way, so why should their healthcare look the same?
The power of preventive and personalised health
Empowering people with their health information can identify risks and personalise their health journey.
Is the dopamine economy impacting your workplace?
Discover how your organisation can step up to the challenge and break the stigma around addiction and dependency and address issues before they reach crisis point.
Dependency and addiction: a health crisis hiding in plain sight
There can be a strong link between poor mental health and dependency susceptibility. Learning about this cycle could help employers recognise the signs and open the dialogue about addiction at work.
The pathway to preventing dependency issues
Online Cognitive Behaviour Therapy (CBT) and resources can help individuals identify root causes and use techniques to strengthen their mental health and resilience, aiming to steer them away from unhealthy habits.
Healthcare is getting personal
Learn how a shift towards personalised healthcare can deliver tailor-made support which helps build healthier teams, reduce absence and drive employee engagement.
DNA dividends
We look at the myriad ways digital technology is being used to provide fast, convenient care and ensure improved and cost-effective outcomes.
What is quiet quitting?
We explore how a generational shift in attitudes to work is part of a bigger challenge around engagement - and the steps you can take to address it.
Prevention is a strategy for success
The business case for promoting workplace wellbeing is compelling. An ageing population, rising levels of obesity and poor mental health mean health prevention must be a priority for organisations seeking to recruit and retain strong teams.
How to provide support for staff struggling with addictive behaviours
We explore how businesses can provide practical advice and tips on the steps organisations can take to support employees who are struggling with addictive behaviours while safeguarding teams and the bottom-line.
Addictive behaviours undermine teams and productivity
Learn about the work patterns and practices that can increase the risk if alcohol and substance abuse and how to ensure the health and safety of teams.
Addiction: nurture and nature
Dr Naveen Puri, Medical Director for Bupa UK Insurance explores the complex interplay between genes, childhood experiences and lifestyles which can drive addiction.
Follow our LinkedIn page
Bringing the latest news and updates directly to your news feed, in real time. We want to hear from you directly, so we encourage you to like, share, comment and ask us questions.